Sjogren syndrome: an autoimmune disorder in which immune cells attack and destroy the glands that produce tears and saliva. Sjögren syndrome is also associated with rheumatic disorders such as rheumatoid arthritis or systemic lupus erythematosus. The hallmark symptoms of Sjögren syndrome are dry mouth and dry eyes. In addition, Sjogren syndrome may cause skin, nose, and vaginal dryness. It also may affect other organs of the body including the kidneys, blood vessels, lungs, liver, pancreas, and brain
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3392 |
4. Check minimum number of eventsNone |
3392 |
5. Include endpointsNone |
3392 |
6. Filter based on genotype QC (FinnGen only) |
3392 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M35
- Name in latin
- Syndroma Sjögren
Similar endpoints
↥List of similar endpoints to
Sicca syndrome [Sjögren]
based on the number of shared cases.
Similar with more cases:
- Other systemic involvement of connective tissue (FG)
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19087 | 16406 | 2577 |
| Only index persons | 17279 | 15035 | 2244 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.41 | 0.47 | 0.07 |
| Only index persons | 0.49 | 0.55 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 56.27 | 56.12 | 57.14 |
| Only index persons | 55.36 | 55.28 | 55.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3392 | 2941 | 451 |
| Unadjusted period prevalence (%) | 0.90 | 1.00 | 0.20 |
| Median age at first event (years) | 54.00 | 53.37 | 58.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3065
- Matched controls
- 30649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
472.6
323.0
339
8
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
14.7
323.0
1433
1728
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
10.4
323.0
745
922
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
6.1
323.0
2325
10413
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
9269.9
323.0
2769
25
P01BA02
ATC
hydroxychloroquine; oral
28.1
323.0
1705
1309
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
1518.0
323.0
397
*
H02AB06
ATC
prednisolone; systemic
4.2
297.4
2110
10537
H04.10
ICD-10 Finland
Dry eye syndrome
6.0
279.6
892
1954
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
6.5
254.9
750
1460
TEA00
NOMESCO Finland
Biopsy of lip
46.2
218.8
270
64
SBA10
NOMESCO Finland
Measurement of excretion of saliva
34.3
207.4
273
87
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
631.3
182.6
179
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.9
177.9
547
1083
M35.1
ICD-10 Finland
Other overlap syndromes
1841.2
173.5
167
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
169.7
1599
8291
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.8
163.7
404
587
L04AX01
ATC
azathioprine; systemic
8.6
154.5
355
459
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.7
144.6
453
903
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
137.5
1633
9299
L88
ICPC
Rheumatoid/seropositive arthritis
7.3
134.4
344
522
M25.5
ICD-10 Finland
Pain in joint
2.7
132.0
1250
6195
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
126.0
1220
6080
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
6.1
115.7
339
614
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.1
115.7
501
1385
ELA30
NOMESCO Finland
Biopsy of salivary gland
82.2
112.1
126
16
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
103.7
99
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
10.8
101.9
203
200
H02AB07
ATC
prednisone; oral
3.0
100.0
674
2613
N03AX16
ATC
pregabalin; oral
2.5
99.7
994
4884
S01XA18
ATC
ciclosporin; ophthalmic
23.6
98.0
142
63
7102B
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]
+∞
91.1
87
*
M79.7
ICD-10 Finland
Fibromyalgia
5.6
88.7
275
529
M35.7
ICD-10 Finland
Hypermobility syndrome
76.3
84.7
96
13
A02BC02
ATC
pantoprazole; systemic
2.2
84.3
2203
16498
E0000UV
ATC
NA
2.1
83.0
1450
9111
S01GX01
ATC
cromoglicic acid; ophthalmic
2.4
82.1
865
4289
N03AX12
ATC
gabapentin; oral
2.7
80.8
672
2923
K11.2
ICD-10 Finland
Sialoadenitis
5.9
79.9
237
431
N02AX02
ATC
tramadol; systemic, rectal
2.1
78.7
1448
9227
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
77.8
380
1143
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.8
75.4
270
608
H02AB04
ATC
methylprednisolone; systemic
2.6
75.1
648
2866
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
13.0
74.8
135
108
L04AA13
ATC
leflunomide; oral
6.1
74.4
212
366
C08CA05
ATC
nifedipine; systemic
4.0
73.6
318
859
K11.70
ICD-10 Finland
Hypoptyalism
18.0
73.3
116
67
A02BC03
ATC
lansoprazole; oral
2.1
72.6
1122
6578
A02BC05
ATC
esomeprazole; systemic
2.0
71.9
1464
9595
A02BC01
ATC
omeprazole; systemic
2.1
71.9
1037
5895
N06AA09
ATC
amitriptyline; systemic
2.9
71.6
508
1991
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.9
71.2
494
1910
ELB10
NOMESCO Finland
Excision of minor salivary gland
57.5
71.2
84
15
A07AA02
ATC
nystatin; oral
3.6
70.0
345
1041
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
7.3
70.0
175
252
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.5
69.7
217
417
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.2
69.7
413
1433
J02AC01
ATC
fluconazole; systemic
2.0
69.6
1603
10964
N06AX21
ATC
duloxetine; oral
2.8
69.4
500
1976
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.4
68.6
268
657
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
68.1
814
4230
R06.0
ICD-10 Finland
Dyspnoea
2.2
67.7
928
5128
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.5
67.5
183
295
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
+∞
66.9
64
*
R68.2
ICD-10 Finland
Dry mouth, unspecified
15.1
66.2
112
77
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
64.8
62
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
64.4
1253
7952
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.5
64.2
175
284
286
Kela drug reimbursment
Ciclosporin eye drop
641.2
64.1
63
*
XX9XE
NOMESCO Finland
Other ultrasound examination
15.1
64.0
108
74
M05BA04
ATC
alendronic acid; oral
2.9
63.9
423
1579
A07EC01
ATC
sulfasalazine; oral, rectal
3.1
63.8
380
1319
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
63.2
1228
7777
M01AH01
ATC
celecoxib; oral (coxibs)
2.2
61.9
741
3827
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
61.0
518
2243
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
33.7
60.4
79
24
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
6.2
60.3
169
285
M13.9
ICD-10 Finland
Arthritis, unspecified
3.3
60.1
327
1061
I73.0
ICD-10 Finland
Raynaud syndrome
9.2
59.9
129
146
UJF32
NOMESCO Finland
Coloscopy
2.1
59.9
928
5345
A01AB09
ATC
miconazole; local oral
2.8
59.7
433
1708
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.0
59.6
254
674
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
57.6
1274
8374
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
56.4
54
*
A01AB04
ATC
amphotericin B; local oral
3.5
55.2
274
826
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
54.3
52
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
54.2
389
1517
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
53.5
987
6032
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
53.2
1317
8920
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
51.8
386
1539
J01FF01
ATC
clindamycin; systemic
1.9
50.7
922
5578
J01MA02
ATC
ciprofloxacin; systemic
1.8
50.6
1212
8078
L93.0
ICD-10 Finland
Discoid lupus erythematosus
26.5
50.4
70
27
M01AH02
ATC
rofecoxib; oral
2.3
50.0
549
2689
R50.9
ICD-10 Finland
Fever, unspecified
2.4
49.6
479
2200
R51.80
ICD-10 Finland
Headache
2.2
48.3
544
2693
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
+∞
48.0
46
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
48.0
46
*
M35
ICD-10 Finland
Other systemic involvement of connective tissue
475.0
47.4
47
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
47.2
901
5521
M79.6
ICD-10 Finland
Pain in limb
1.8
46.9
1221
8302
SBB10
NOMESCO Finland
Teeth copy
3.3
46.5
253
817
J01DA01
ATC
[U] cefalexin; systemic
1.8
46.4
1994
15793
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
46.2
340
1340
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
46.1
1092
7187
R03AC02
ATC
salbutamol; inhalant
1.7
45.7
1719
13043
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
45.3
624
3365
A02BA02
ATC
ranitidine; systemic
2.0
44.1
702
4005
M01AC06
ATC
meloxicam; systemic, rectal
1.7
43.9
1274
8901
J01AA02
ATC
doxycycline; systemic
1.9
43.7
2487
21307
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
13.6
43.5
76
57
R06AE07
ATC
cetirizine; oral
1.7
43.3
1453
10586
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
43.3
667
3752
J01DB01
ATC
cefalexin; oral
1.9
43.2
2513
21628
S01KA02
ATC
hypromellose; ophthalmic
5.1
42.9
141
288
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
42.8
41
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.4
42.8
134
259
K90.0
ICD-10 Finland
Coeliac disease
4.4
42.5
162
386
N02BE01
ATC
paracetamol; systemic, rectal
2.1
42.5
2705
23980
H03AA01
ATC
levothyroxine sodium; systemic
1.8
41.4
932
5982
L04AA06
ATC
mycophenolic acid; systemic
7.6
41.3
99
134
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.1
41.3
168
426
J01FA10
ATC
azithromycin; systemic
1.7
41.0
1839
14468
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
40.9
338
1422
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
4.2
40.3
159
392
R13
ICD-10 Finland
Dysphagia
2.9
40.2
266
980
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
37.0
40.0
51
14
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
39.7
38
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
39.6
442
2162
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.6
39.3
142
321
M54.5
ICD-10 Finland
Low back pain
1.7
39.0
1061
7197
J05AB01
ATC
aciclovir; systemic
1.9
39.0
755
4591
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
39.0
624
3546
K07.60
ICD-10 Finland
Snapping jaw
3.1
38.9
228
775
N03AE01
ATC
clonazepam; systemic
2.9
38.5
247
892
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
38.5
775
4773
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.6
38.4
101
157
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.7
38.1
173
483
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
38.1
575
3191
TGC00
NOMESCO Finland
Bronchial lavation
5.0
38.0
125
256
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.4
37.8
143
338
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
37.6
437
2172
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.4
37.5
355
1600
M79.1
ICD-10 Finland
Myalgia
2.1
37.4
469
2408
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
37.3
1606
12341
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
37.1
375
1747
J01FA06
ATC
roxithromycin; oral
1.6
37.0
1330
9723
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.1
36.9
216
732
G44.2
ICD-10 Finland
Tension-type headache
2.1
36.8
499
2649
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
36.7
1304
9502
R01AD08
ATC
fluticasone; nasal
1.7
36.5
939
6233
M33.2
ICD-10 Finland
Polymyositis
+∞
36.5
35
*
R01AD09
ATC
mometasone; nasal
1.6
35.9
1438
10797
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
12.0
35.8
66
56
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
35.5
859
5586
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
7.0
35.4
89
130
M01CB03
ATC
auranofin; oral
8.3
35.2
79
97
SBA00
NOMESCO Finland
Microbiological examinations
4.4
35.1
131
306
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.5
35.1
307
1326
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
34.7
368
1748
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
34.6
498
2702
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.7
34.6
102
184
M01AE02
ATC
naproxen; oral, rectal
1.6
34.5
1748
13885
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
34.2
727
4533
R53
ICD-10 Finland
Malaise and fatigue
1.8
34.1
663
4011
R05
ICD-10 Finland
Cough
1.8
34.1
674
4101
M01AH05
ATC
etoricoxib; oral
1.6
34.1
1821
14639
XPX04
NOMESCO Finland
Angioscopy
24.3
34.0
48
20
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
33.9
734
4598
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
33.9
243
937
N06AX16
ATC
venlafaxine; oral
2.0
33.9
494
2693
M01AB55
ATC
diclofenac, combinations; oral
2.5
33.8
282
1186
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
5.2
33.8
108
214
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
33.7
1398
10527
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
33.5
353
1670
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
33.2
622
3711
J31.0
ICD-10 Finland
Chronic rhinitis
2.4
32.8
291
1267
ZX120
NOMESCO Finland
Intravenous
2.3
32.7
331
1538
N06AX11
ATC
mirtazapine; oral
1.7
32.7
1018
7089
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
32.7
1916
15685
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.2
32.6
128
314
J01MA12
ATC
levofloxacin; systemic
1.9
32.6
560
3238
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
32.5
537
3063
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
32.5
2105
17659
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
32.4
256
1046
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
32.3
31
*
73490
ICD-8 Finland
Diffuse diseases of connective tissue, Keratonconjunctivitis sicca
+∞
32.3
31
*
M05BA07
ATC
risedronic acid; oral
3.2
32.2
175
563
UKC02
NOMESCO Finland
Cystoscopy
2.1
32.2
428
2246
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.8
32.1
219
821
N06AB04
ATC
citalopram; systemic
1.7
32.0
738
4703
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.9
31.9
91
158
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.7
31.6
110
240
N05CF01
ATC
zopiclone; oral
1.6
31.5
1023
7191
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
+∞
31.3
30
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.5
31.2
263
1112
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
60.7
31.1
36
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
31.1
949
6553
D07AC01
ATC
betamethasone; topical
1.6
31.1
1047
7421
M01AX17
ATC
nimesulide; oral
1.7
31.1
820
5435
A01
ICPC
Pain general/multiple sites
2.4
30.9
294
1321
E000006
ATC
NA
2.4
30.6
289
1296
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
30.5
623
3813
R4120
NOMESCO Finland
Occupational therapy
2.6
30.2
236
957
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
38.5
30.2
38
10
K02.1
ICD-10 Finland
Caries of dentine
1.6
30.1
1628
12938
EBB10
NOMESCO Finland
Insertion of dental implant
5.9
30.0
86
150
L04AA01
ATC
[U] ciclosporin; systemic
5.7
30.0
88
158
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
30.0
558
3309
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
7.0
30.0
75
109
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
29.7
571
3423
P01AB01
ATC
metronidazole; oral, rectal
1.6
29.6
1301
9829
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
29.4
367
1869
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
29.3
281
1268
M01CB01
ATC
sodium aurothiomalate; parenteral
5.1
29.3
95
192
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
29.3
391
2050
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
29.2
894
6153
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
29.2
223
893
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
29.2
1155
8495
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.0
29.1
96
198
Z01.2
ICD-10 Finland
Dental examination
1.6
29.0
1242
9306
E000001
ATC
NA
1.7
28.9
652
4108
L28
ICPC
Limited function/disability (L)
1.9
28.8
504
2920
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.2
28.8
156
501
M03BX02
ATC
tizanidine; oral
1.5
28.8
1894
15682
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
28.5
298
1403
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
28.5
308
1474
A01AB10
ATC
natamycin; local oral
3.5
28.2
139
416
R06AX27
ATC
desloratadine; oral
1.6
28.1
866
5959
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
28.0
369
1924
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
27.9
457
2586
H16.0
ICD-10 Finland
Corneal ulcer
3.0
27.9
166
569
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.7
27.8
197
755
SXA10
NOMESCO Finland
Epithel biopsy of mouth
6.0
27.8
78
133
XQ800
NOMESCO Finland
Prick test
2.3
27.6
272
1244
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
27.5
347
1774
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.3
27.4
142
441
M02AA07
ATC
piroxicam; topical
1.5
27.4
1181
8825
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.3
27.4
104
248
R01AD01
ATC
beclometasone; nasal
1.8
27.3
515
3057
M01AX01
ATC
nabumetone; oral
2.7
27.3
191
727
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
27.2
534
3210
N02AA05
ATC
oxycodone; systemic
1.9
27.1
429
2395
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
27.1
173
622
ZX140
NOMESCO Finland
Intra articular
8.2
27.1
61
76
R03DC03
ATC
montelukast; oral
1.8
26.9
541
3281
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.4
26.6
234
1010
G47.3
ICD-10 Finland
Sleep apnoea
1.8
26.6
562
3460
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
26.6
216
895
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
26.5
1487
11770
M70.6
ICD-10 Finland
Trochanteric bursitis
1.8
26.4
482
2828
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.0
26.3
361
1909
K11.7
ICD-10 Finland
Disturbances of salivary secretion
37.0
26.1
33
9
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
26.0
203
821
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
26.0
122
351
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.2
25.9
279
1331
XKD00
NOMESCO Finland
Uroflowmetry
2.2
25.6
290
1412
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.4
25.4
77
145
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.7
25.1
182
707
D06BX01
ATC
metronidazole; topical
1.9
25.1
388
2145
Z01.9
ICD-10 Finland
Special examination, unspecified
2.4
25.1
216
923
L03
ICPC
Low back symptom/complaint
1.6
25.0
759
5170
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
25.0
24
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
25.0
24
*
L17
ICPC
Foot/toe symptom/complaint
1.6
25.0
786
5404
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
58.5
25.0
29
5
J01FA09
ATC
clarithromycin; systemic
1.5
24.9
987
7189
D07AC13
ATC
mometasone; topical
1.6
24.8
867
6124
E000002
ATC
NA
1.9
24.8
370
2020
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
24.7
1077
8014
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
24.7
803
5568
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
24.5
237
1073
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.7
24.5
176
678
A03FA02
ATC
cisapride; oral, rectal
2.1
24.4
286
1416
J05AB11
ATC
valaciclovir; oral
1.8
24.2
444
2603
SFA00
NOMESCO Finland
Small filling
1.9
24.2
409
2335
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
24.1
1405
11121
H01.0
ICD-10 Finland
Blepharitis
2.5
24.1
201
845
K30
ICD-10 Finland
Functional dyspepsia
1.9
24.0
368
2026
WX110
NOMESCO Finland
Local anesthesy
1.5
24.0
2003
17095
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
24.0
526
3266
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
23.8
1617
13209
R35
ICD-10 Finland
Polyuria
2.6
23.8
183
736
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.6
23.6
179
713
A02BX02
ATC
sucralfate; oral
2.8
23.6
157
579
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.1
23.6
137
463
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
23.5
360
1980
TAB00
NOMESCO Finland
Lumbar puncture
2.8
23.4
159
595
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
23.3
1771
14773
J01EA01
ATC
trimethoprim; systemic
1.5
23.3
896
6457
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
23.3
253
1211
M54.6
ICD-10 Finland
Pain in thoracic spine
2.3
23.1
233
1078
NG1DA
NOMESCO Finland
X-ray of knees
4.3
23.0
86
203
J01MA14
ATC
moxifloxacin; systemic
2.1
23.0
271
1342
C07AB07
ATC
bisoprolol; oral
1.5
22.9
1309
10286
XG410
NOMESCO Finland
Flow-volume spirometry
2.9
22.7
144
516
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
14.2
22.6
38
27
K74.3
ICD-10 Finland
Primary biliary cirrhosis
7.3
22.5
54
75
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.4
22.4
205
905
C03CA01
ATC
furosemide; systemic
1.6
22.3
754
5255
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.7
21.8
75
163
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
6.6
21.8
56
86
R52.2
ICD-10 Finland
Other chronic pain
2.9
21.7
133
466
WZA90
NOMESCO Finland
Other doctors statement
1.6
21.7
667
4533
N02AC04
ATC
dextropropoxyphene; oral
2.9
21.6
132
463
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
21.5
1168
9041
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
21.4
277
1427
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
21.4
256
1278
104
Kela drug reimbursment
Thyroid insufficiency
2.0
21.3
295
1560
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
21.3
813
5824
L04AB01
ATC
etanercept; parenteral
4.6
21.3
75
167
S01AX11
ATC
[U] ofloxacin; ophthalmic
2.9
21.3
131
461
M05BA06
ATC
ibandronic acid; systemic
3.5
21.3
101
295
R03BA08
ATC
ciclesonide; inhalant
2.0
21.2
288
1512
M05BX04
ATC
denosumab; parenteral
2.4
21.2
194
856
N05BA01
ATC
diazepam; systemic, rectal
1.8
21.2
421
2530
EAA10
NOMESCO Finland
Excision of lesion of lip
5.3
21.2
65
125
R52.9
ICD-10 Finland
Pain, unspecified
2.0
21.1
283
1479
M54.2
ICD-10 Finland
Cervicalgia
2.2
21.1
235
1134
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
21.0
689
4754
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
21.0
998
7501
SXC03
NOMESCO Finland
Other oral or dental procedure
6.4
20.9
55
87
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
8.1
20.9
47
59
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
20.8
1638
13615
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
20.8
567
3733
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.4
20.7
186
813
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
20.6
692
4801
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
20.5
231
1120
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.0
20.5
288
1531
-1
NOMESCO Finland
NA
1.5
20.4
927
6892
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
20.4
351
2010
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
20.4
214
1008
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
20.3
216
1024
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
20.2
218
1038
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.0
20.2
65
132
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.3
20.2
104
324
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
20.1
1303
10399
R01AD12
ATC
fluticasone furoate; nasal
1.5
20.0
872
6418
J01CA04
ATC
amoxicillin; systemic
1.5
20.0
2383
21410
L99
ICPC
Musculoskeletal disease other
3.9
20.0
83
217
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
20.0
77
188
L01
ICPC
Neck symptom/complaint
1.7
19.9
432
2663
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
4.6
19.9
69
152
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
19.8
19
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
19.8
328
1851
R01AD11
ATC
triamcinolone; nasal
1.9
19.8
296
1609
R03BA01
ATC
beclometasone; inhalant
1.7
19.7
443
2757
S18
ICPC
Laceration/cut
1.4
19.6
1180
9276
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
19.5
858
6320
N30.0
ICD-10 Finland
Acute cystitis
1.7
19.4
479
3062
R07.3
ICD-10 Finland
Other chest pain
1.9
19.4
289
1571
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
19.3
127
466
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
19.3
361
2122
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.5
19.3
152
619
AA1AD
NOMESCO Finland
CT of head and brain
1.6
19.3
651
4513
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.4
19.2
95
287
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.6
19.2
141
553
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.4
19.1
93
278
WX002
NOMESCO Finland
Sedation and analgesia
1.6
19.1
589
3993
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.2
19.0
202
954
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
19.0
273
1462
H16.9
ICD-10 Finland
Keratitis, unspecified
4.5
19.0
68
155
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
6.9
18.9
47
69
K02.0
ICD-10 Finland
Caries limited to enamel
1.8
18.9
373
2229
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.0
18.9
114
396
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
3.8
18.8
80
214
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
18.8
569
3838
N05CD07
ATC
temazepam; oral
1.8
18.8
378
2275
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
5.8
18.7
53
93
H57.1
ICD-10 Finland
Ocular pain
2.8
18.6
122
446
N06AB06
ATC
sertraline; oral
1.8
18.5
333
1930
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
18.5
247
1289
PAW37
NOMESCO Finland
Biopsy of temporal artery
11.4
18.5
34
30
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
5.2
18.4
57
111
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
18.4
178
805
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
18.4
448
2849
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
18.4
203
979
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.2
18.4
202
969
E000007
ATC
NA
2.2
18.4
195
922
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
2.4
18.3
156
665
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.9
18.3
60
125
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
25.2
18.2
25
10
M01AB05
ATC
diclofenac; systemic, rectal
1.4
18.2
1937
16821
XCK00
NOMESCO Finland
Perimetry
2.0
18.2
226
1146
D07AB08
ATC
desonide; topical
1.8
18.1
318
1830
L12
ICPC
Hand/finger symptom/complaint
1.7
18.1
422
2650
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
4.5
18.1
64
144
SPAT1229
SPAT
Assessment of need for aid
2.0
18.1
252
1334
SPAT1263
SPAT
Sampling
1.4
18.1
1225
9795
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.2
18.1
181
834
R42
ICD-10 Finland
Dizziness and giddiness
1.5
18.0
652
4584
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.1
18.0
202
980
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
18.0
374
2273
SPAT1301
SPAT
No procedures
1.5
17.9
914
6917
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
10.7
17.9
34
32
F45.8
ICD-10 Finland
Other somatoform disorders
2.1
17.9
213
1060
Z00.0
ICD-10 Finland
General medical examination
1.6
17.8
515
3426
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
17.8
234
1212
EBB15
NOMESCO Finland
Insertion of dental implant abutment
6.7
17.8
45
68
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.1
17.8
205
1005
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
17.8
235
1218
J02AC02
ATC
itraconazole; systemic
1.6
17.8
567
3868
N16.4*M35.0
ICD-10 Finland
Sjögren's syndrome with renal tubulo-interstitial disorders
+∞
17.7
17
*
C07AA05
ATC
propranolol; systemic
1.6
17.7
588
4050
B37.08
ICD-10 Finland
Other candidal stomatitis
6.6
17.6
45
69
N05BA12
ATC
alprazolam; oral
1.8
17.6
329
1934
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
17.6
290
1635
M32
ICD-10 Finland
Systemic lupus erythematosus
95.6
17.6
19
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
17.5
173
793
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
4.7
17.5
60
131
R03BA05
ATC
fluticasone; inhalant
1.6
17.5
543
3677
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
17.4
121
461
A02BA04
ATC
nizatidine; systemic
2.0
17.4
240
1266
R05
ICPC
Cough
1.5
17.3
667
4752
J01DA06
ATC
[U] cefuroxime; systemic
1.6
17.3
439
2821
L04AD01
ATC
ciclosporin; systemic
3.9
17.3
71
185
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
17.2
605
4220
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.1
17.2
197
965
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
5.4
17.2
51
95
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
11.1
17.2
32
29
A01AC01
ATC
triamcinolone; local oral
3.6
17.2
79
226
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
17.2
454
2951
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
17.2
129
513
S01BC03
ATC
diclofenac; ophthalmic
3.1
17.1
95
313
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
17.1
323
1903
D02AE01
ATC
carbamide; topical
2.0
17.1
213
1079
NDL52
NOMESCO Finland
Tenosynovectomy of hand
6.0
17.1
47
80
SPAT1153
SPAT
Removal of sutures
1.4
17.0
915
6982
CCC00
NOMESCO Finland
Occlusion of lacrimal punctum or canaliculus
31.6
17.0
22
7
A04
ICPC
Weakness/tiredness general
1.7
17.0
370
2274
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
5.0
17.0
54
109
C05AA08
ATC
fluocortolone; rectal, topical
1.6
16.9
430
2765
S01AD03
ATC
aciclovir; ophthalmic
2.5
16.8
138
577
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
16.7
338
2032
L71.8
ICD-10 Finland
Other rosacea
4.1
16.6
64
157
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
9.3
16.6
34
37
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
16.6
366
2259
M02AA10
ATC
ketoprofen; topical
1.6
16.6
487
3250
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
16.5
474
3143
F34.1
ICD-10 Finland
Dysthymia
2.6
16.5
123
488
N05BA04
ATC
oxazepam; oral
1.5
16.5
746
5492
N04BC05
ATC
pramipexole; oral
1.9
16.5
237
1268
H16.2
ICD-10 Finland
Keratoconjunctivitis
6.8
16.5
41
61
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
3.4
16.5
81
245
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
16.4
225
1184
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
16.4
531
3628
R02
ICPC
Shortness of breath/dyspnoea
1.7
16.4
348
2126
C01CA24
ATC
epinephrine; parenteral
2.1
16.3
197
988
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.4
16.2
139
593
K11.5
ICD-10 Finland
Sialolithiasis
4.1
16.2
63
156
M48.0
ICD-10 Finland
Spinal stenosis
1.7
16.2
350
2146
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
16.2
878
6697
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
16.2
400
2550
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
16.1
362
2245
QDH05
NOMESCO Finland
Correction of deformity of toe nail
12.8
16.1
28
22
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
4.9
16.1
52
107
R4110
NOMESCO Finland
Physiotherapy
1.5
16.1
749
5542
S01GX05
ATC
lodoxamide; ophthalmic
3.7
16.1
70
192
UEL02
NOMESCO Finland
Sialoscopy
11.7
16.0
29
25
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
16.0
359
2229
R06AX13
ATC
loratadine; oral
1.6
16.0
468
3121
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
15.9
281
1615
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.4
15.9
77
230
SPAT1325
SPAT
Vaccination
1.4
15.9
968
7540
Z50.1
ICD-10 Finland
Other physical therapy
2.1
15.9
181
885
C08CA01
ATC
amlodipine; oral
1.4
15.9
938
7266
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
15.9
727
5361
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
3.6
15.8
70
195
F29
ICPC
Eye symptom/complaint other
1.9
15.8
247
1364
R00.2
ICD-10 Finland
Palpitations
1.9
15.7
232
1256
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.5
15.7
127
526
R03AC03
ATC
terbutaline; inhalant
1.6
15.6
432
2835
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
6.3
15.6
41
66
J01FA01
ATC
erythromycin; systemic
1.6
15.6
409
2646
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
6.1
15.6
42
70
ZXA00
NOMESCO Finland
Right side
1.4
15.5
773
5794
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
15.4
203
1051
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
9.5
15.4
31
33
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
15.3
124
514
C03DA01
ATC
spironolactone; oral
1.8
15.3
283
1654
G62.8
ICD-10 Finland
Other specified polyneuropathies
7.1
15.3
37
53
H02AB09
ATC
hydrocortisone; systemic
3.1
15.2
82
266
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
10.4
15.2
29
28
G50.1
ICD-10 Finland
Atypical facial pain
3.2
15.1
78
245
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
15.1
643
4661
D07AA02
ATC
hydrocortisone; topical
1.7
15.1
369
2342
L20
ICPC
Joint symptom/complaint NOS
2.5
15.1
123
513
SPAT1240
SPAT
Therapeutic discussion
1.8
15.1
286
1686
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
14.9
213
1140
R03BA02
ATC
budesonide; inhalant
1.5
14.9
514
3557
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
14.8
236
1313
D06BB04
ATC
podophyllotoxin; topical
2.3
14.8
133
583
D07AD01
ATC
clobetasol; topical
1.6
14.8
471
3199
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
2.7
14.8
100
376
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
3.8
14.7
61
161
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
14.6
252
1438
7109X
ICD-9 Finland
Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease
+∞
14.6
14
*
73491
ICD-8 Finland
Diffuse diseases of connective tissue, Collagenosis NUD
+∞
14.6
14
*
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
14.6
14
*
L93.2
ICD-10 Finland
Other local lupus erythematosus
80.5
14.6
16
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
14.5
184
941
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.7
14.5
102
392
SPAT1216
SPAT
Assessment of functional ability
1.6
14.4
418
2772
N35.0
ICD-10 Finland
Post-traumatic urethral stricture
36.2
14.4
18
5
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
6.4
14.4
37
58
R06AX22
ATC
ebastine; oral
1.5
14.4
524
3671
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
14.4
1129
9153
M54.1
ICD-10 Finland
Radiculopathy
2.3
14.4
133
592
P01BA01
ATC
chloroquine; systemic
6.2
14.4
38
62
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
14.3
350
2221
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
14.3
471
3227
L01CB
ATC
Podophyllotoxin derivatives
11.4
14.3
26
23
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
11.4
14.3
26
23
SPAT1312
SPAT
General health counselling
1.4
14.2
893
6965
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.4
14.1
120
512
L29
ICPC
Musculoskeletal sympt/complt other
1.9
14.1
224
1244
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.7
14.1
47
101
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
7.0
14.1
34
49
R06AE09
ATC
levocetirizine; oral
1.6
14.1
427
2863
NDG30
NOMESCO Finland
Fusion of wrist, total
6.0
14.0
38
64
N05CF02
ATC
zolpidem; oral
1.5
14.0
518
3637
M05BA01
ATC
etidronic acid; systemic
5.5
14.0
41
76
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.1
13.9
77
255
B01AB05
ATC
enoxaparin; parenteral
1.4
13.9
873
6804
L04AB04
ATC
adalimumab; parenteral
3.4
13.9
68
206
K07.23
ICD-10 Finland
Deep bite
3.5
13.9
64
185
S01GX09
ATC
olopatadine; ophthalmic
2.7
13.9
98
377
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.3
13.9
130
583
SPAT1260
SPAT
Consultation of another employee
1.5
13.8
520
3666
A06AD11
ATC
lactulose; oral
1.6
13.8
370
2403
EMAK
NOMESCO Finland
NA
2.4
13.8
123
535
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
13.8
99
386
XQ802
NOMESCO Finland
Epicutan test
2.2
13.8
136
623
SPC01
NOMESCO Finland
Fixed dental crown
4.2
13.8
51
122
N03AF01
ATC
carbamazepine; oral, rectal
2.1
13.7
156
763
R30.0
ICD-10 Finland
Dysuria
2.4
13.7
111
463
H10.4
ICD-10 Finland
Chronic conjunctivitis
4.2
13.6
51
123
J01MA06
ATC
norfloxacin; oral
1.5
13.6
437
2972
J47
ICD-10 Finland
Bronchiectasis
3.3
13.6
69
215
318
Kela drug reimbursment
Teriparatide
6.2
13.6
36
59
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.5
13.6
47
105
L95
ICPC
Osteoporosis
2.4
13.6
119
515
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.6
428
2898
R03AC12
ATC
salmeterol; inhalant
2.2
13.6
135
621
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
13.5
13
*
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.5
13.5
63
184
A28
ICPC
Limited function/disability NOS
1.6
13.5
388
2568
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
13.4
697
5241
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
13.4
91
342
N06AB03
ATC
fluoxetine; oral
1.6
13.4
382
2523
S01GX02
ATC
levocabastine; ophthalmic
1.9
13.4
193
1036
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
13.4
793
6112
EAA00
NOMESCO Finland
Incision of lip
25.8
13.4
18
7
N06AA10
ATC
nortriptyline; systemic
2.9
13.3
82
290
A02BC04
ATC
rabeprazole; oral
1.7
13.3
261
1552
L04AA11
ATC
[U] etanercept; parenteral
8.1
13.3
29
36
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.7
13.3
37
65
R60.0
ICD-10 Finland
Localized oedema
1.7
13.3
315
1981
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
13.2
386
2561
KMAK
NOMESCO Finland
NA
1.3
13.2
1443
12274
SXC05
NOMESCO Finland
Other oral or dental procedure
2.0
13.1
160
804
G03CA04
ATC
estriol; systemic, vaginal
1.7
13.1
273
1652
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
4.6
13.1
45
100
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
13.1
273
1656
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
13.0
112
479
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.6
13.0
322
2049
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.5
13.0
576
4197
S01GX08
ATC
ketotifen; ophthalmic
2.3
12.9
123
555
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
12.9
107
452
A03
ICPC
Fever
1.6
12.9
399
2686
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
4.9
12.9
41
84
XA402
NOMESCO Finland
ENMG
2.6
12.9
90
346
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.4
12.9
61
181
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
12.9
913
7246
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
12.9
339
2195
M01AB08
ATC
etodolac; oral
1.8
12.8
233
1352
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
12.8
706
5364
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.1
12.8
142
687
C09CA06
ATC
candesartan; oral
1.4
12.8
601
4428
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.9
12.8
75
259
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
12.8
95
378
N06AG02
ATC
moclobemide; oral
2.1
12.7
148
729
L08
ICPC
Shoulder symptom/complaint
1.5
12.7
535
3858
ZXA05
NOMESCO Finland
Left side
1.4
12.6
712
5427
WX290
NOMESCO Finland
Other blockade of nerve
1.3
12.6
1132
9321
R4180
NOMESCO Finland
Podiatric therapy
4.3
12.6
46
109
C10AC01
ATC
colestyramine; oral
2.6
12.6
94
375
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
3.2
12.6
64
201
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
12.5
232
1354
R05FB02
ATC
cough suppressants and expectorants
1.3
12.5
1112
9137
SPAT1310
SPAT
Counselling related to known health issue
1.4
12.5
893
7088
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.9
12.5
74
257
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
12.5
12
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
12.5
12
*
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
12.5
12
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
12.5
12
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.9
12.5
199
1108
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.8
12.5
78
281
RT271
NOMESCO Finland
NA
9.3
12.5
25
27
NXL00
NOMESCO Finland
Biopsy of muscle
9.3
12.5
25
27
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
12.4
155
788
UJD02
NOMESCO Finland
Gastroscopy
2.1
12.4
146
726
S01XA02
ATC
retinol; ophthalmic
5.4
12.4
36
67
L04AA17
ATC
[U] adalimumab; parenteral
6.9
12.4
30
44
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
12.3
784
6101
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
8.0
12.3
27
34
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
12.3
360
2391
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
12.3
122
564
SPF20
NOMESCO Finland
Temporary soling for filling
4.4
12.3
43
98
SPAT1097
SPAT
Recording of ECG
1.5
12.2
414
2844
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
12.2
531
3847
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
9.0
12.2
25
28
Z71.8
ICD-10 Finland
Other specified counselling
1.4
12.2
634
4760
L13
ICPC
Hip symptom/complaint
1.5
12.2
472
3342
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
12.2
162
845
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.7
12.2
53
147
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
12.2
290
1825
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
12.2
137
666
G04BD12
ATC
mirabegron; oral
1.6
12.2
293
1851
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.8
12.1
50
133
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
12.1
322
2089
XF404
NOMESCO Finland
Ambulatory ECG
1.7
12.1
247
1489
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.6
12.1
320
2071
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
12.1
188
1036
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.8
12.1
33
57
J01MA01
ATC
ofloxacin; systemic
1.7
12.0
231
1364
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
26.8
12.0
16
6
R07.0
ICD-10 Finland
Pain in throat
1.9
12.0
166
876
N05AH04
ATC
quetiapine; oral
1.5
12.0
404
2775
M54.3
ICD-10 Finland
Sciatica
1.9
12.0
176
953
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
5.0
12.0
37
74
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.7
12.0
83
318
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
11.9
644
4867
H05AA02
ATC
teriparatide; parenteral
6.0
11.9
32
54
N06AB10
ATC
escitalopram; oral
1.4
11.9
540
3945
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.5
11.9
90
362
1XC02
NOMESCO Finland
NA
5.5
11.9
34
62
L30.8
ICD-10 Finland
Other specified dermatitis
2.9
11.9
70
243
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
11.9
373
2518
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
11.8
249
1514
9531
FHL
Arthrodesis of the hand joint
7.1
11.8
28
40
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
14.7
11.8
19
13
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
14.7
11.8
19
13
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
11.8
370
2499
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
11.7
227
1347
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.4
11.7
95
396
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.0
11.7
65
218
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.7
11.7
77
286
G72.9
ICD-10 Finland
Myopathy, unspecified
6.3
11.7
30
48
XA800
NOMESCO Finland
Neuropsychological investigation
2.3
11.7
107
477
120
Kela drug reimbursment
Hypogammaglobulinaemia
16.5
11.7
18
11
R51.81
ICD-10 Finland
Facial pain NOS
2.6
11.6
81
311
L50.9
ICD-10 Finland
Urticaria, unspecified
2.3
11.6
108
483
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
11.6
195
1107
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
11.5
716
5538
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.2
11.5
60
192
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
11.5
11
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
11.5
11
*
R04.2
ICD-10 Finland
Haemoptysis
2.6
11.5
80
308
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.4
11.4
689
5302
9527
FHL
Alloarthroplasty, implant or endoprosthesis
13.6
11.4
19
14
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.0
11.4
45
115
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
11.4
156
823
C08CA02
ATC
felodipine; oral
1.7
11.4
239
1451
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
11.4
128
625
R74
ICPC
Upper respiratory infection acute
1.4
11.4
753
5886
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.0
11.4
149
772
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
11.4
129
630
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
11.4
201
1160
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.0
11.4
44
111
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.8
11.3
73
269
L04AA24
ATC
abatacept; parenteral
6.0
11.3
30
50
R06.5
ICD-10 Finland
Mouth breathing
1.8
11.3
204
1184
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.3
11.3
105
471
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
11.3
115
538
ZXA10
NOMESCO Finland
Bilateral
1.4
11.3
519
3801
SPAT1254
SPAT
Administration of medicine
1.5
11.3
369
2514
K08.3
ICD-10 Finland
Retained dental root
1.9
11.3
176
973
SPAT1255
SPAT
Intravenous administration of medicine
1.9
11.3
170
928
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
11.3
126
613
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.1
11.2
122
588
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.7
11.2
47
127
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.1
11.2
59
191
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.1
11.1
128
631
H04.1
ICD-10 Finland
Other disorders of lacrimal gland
25.1
11.1
15
6
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.1
11.1
125
610
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.4
11.1
95
410
R03AC13
ATC
formoterol; inhalant
1.9
11.1
153
810
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
11.1
122
589
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.5
11.1
88
365
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
11.0
110
509
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
7.1
11.0
26
37
C07AB02
ATC
metoprolol; systemic
1.4
11.0
527
3885
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
6.6
10.9
27
41
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
10.9
323
2150
B02.9
ICD-10 Finland
Zoster without complication
1.9
10.9
169
932
H93.1
ICD-10 Finland
Tinnitus
1.8
10.9
186
1061
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
10.9
277
1772
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.3
10.9
53
162
J01AA07
ATC
tetracycline; systemic
1.5
10.9
405
2839
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
10.8
392
2732
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
10.8
1267
10769
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
3.4
10.8
50
147
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
10.8
136
695
9522
FHL
Synovectomy
8.3
10.8
23
28
E000003
ATC
NA
2.0
10.8
129
645
M45
ICD-10 Finland
Ankylosing spondylitis
3.0
10.8
62
212
A02BA03
ATC
famotidine; systemic
2.2
10.8
109
510
S01GX04
ATC
nedocromil; ophthalmic
2.9
10.7
63
219
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
10.7
162
886
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
7.2
10.7
25
35
G54.0
ICD-10 Finland
Brachial plexus disorders
2.6
10.7
79
314
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
10.7
480
3495
R49.01
ICD-10 Finland
Functional dysphonia
2.2
10.7
103
470
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.1
10.7
120
586
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.8
10.7
65
232
UDC00
NOMESCO Finland
Ear microscopy
1.8
10.7
191
1106
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
10.7
1132
9491
WW200
NOMESCO Finland
Immunization
2.5
10.7
82
334
EKA10
NOMESCO Finland
Biopsy of cheek
2.6
10.6
76
298
TNG10
NOMESCO Finland
Puncture of knee
3.8
10.6
43
113
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
10.6
324
2168
RT274
NOMESCO Finland
NA
12.9
10.6
18
14
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.6
10.6
78
308
K12.18
ICD-10 Finland
Other forms of stomatitis
5.0
10.6
33
67
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.1
10.6
40
99
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
10.6
115
555
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
5.1
10.6
32
63
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
10.6
183
1049
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.8
10.6
67
245
J01AA04
ATC
lymecycline; systemic
1.5
10.5
323
2167
R76.0
ICD-10 Finland
Raised antibody titre
8.5
10.5
22
26
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
10.5
240
1493
H10
ICD-10 Finland
Conjunctivitis
1.8
10.5
173
975
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.6
10.5
279
1808
K03.00
ICD-10 Finland
Approximal wear
2.0
10.5
140
733
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.0
10.5
60
204
H26.4
ICD-10 Finland
After-cataract
1.6
10.5
254
1608
H02AB08
ATC
triamcinolone; systemic
6.2
10.4
27
44
K08.80
ICD-10 Finland
Toothache NOS
1.7
10.4
218
1324
7108X
ICD-9 Finland
Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue
+∞
10.4
10
*
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
5.9
10.4
28
48
L43.9
ICD-10 Finland
Lichen planus, unspecified
2.6
10.4
71
272
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
4.8
10.4
33
69
B81
ICPC
Anaemia vit B12/folate deficiency
2.2
10.4
105
489
J45.8
ICD-10 Finland
Mixed asthma
2.3
10.4
90
392
UJH02
NOMESCO Finland
Anoscopy
2.0
10.4
128
648
R51
ICD-10 Finland
Headache
1.9
10.3
145
773
RT172
NOMESCO Finland
NA
16.1
10.3
16
10
R21
ICPC
Throat symptom/complaint
1.4
10.3
497
3665
D68.8
ICD-10 Finland
Other specified coagulation defects
4.2
10.3
38
92
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
10.3
191
1119
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
6.0
10.3
27
45
D02AX
ATC
Other emollients and protectives
2.2
10.2
99
451
P03
ICPC
Feeling depressed
1.7
10.2
226
1395
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.8
10.2
65
239
J01FA15
ATC
telithromycin; oral
1.6
10.2
286
1878
NHG22
NOMESCO Finland
Fusion of subtalar joint
5.0
10.1
31
62
N03AX09
ATC
lamotrigine; oral
2.0
10.1
123
622
9272
FHL
Metatarsophalangeal joint resection
6.2
10.1
26
42
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
10.1
511
3804
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
4.1
10.1
38
94
SPB10
NOMESCO Finland
Production of temporary crone to tooth
4.1
10.1
38
94
K76.9
ICD-10 Finland
Liver disease, unspecified
3.3
10.1
49
150
G04BD04
ATC
oxybutynin; oral, transdermal
1.8
10.1
175
1002
EB1WA
NOMESCO Finland
NA
5.6
10.1
28
50
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.3
10.1
94
424
F01
ICPC
Eye pain
2.4
10.1
85
365
R15
ICD-10 Finland
Faecal incontinence
2.2
10.0
98
452
L29.9
ICD-10 Finland
Pruritus, unspecified
2.5
10.0
75
303
U02
ICPC
Urinary frequency/urgency
1.5
10.0
406
2899
K12.10
ICD-10 Finland
Stomatitis NOS
5.8
9.9
27
47
L43.8
ICD-10 Finland
Other lichen planus
2.7
9.9
67
254
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
9.9
381
2685
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
2.7
9.9
64
238
K59.0
ICD-10 Finland
Constipation
1.8
9.9
153
847
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.5
9.8
74
299
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
9.8
642
4991
R03AK08
ATC
formoterol and beclometasone; inhalant
2.1
9.8
111
543
A29
ICPC
General symptom/complaint other
1.6
9.8
281
1854
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
2.3
9.8
91
407
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
8.1
9.8
21
26
A46
ICD-10 Finland
Erysipelas
1.5
9.8
320
2178
R06.4
ICD-10 Finland
Hyperventilation
2.9
9.8
57
198
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
9.6
9.7
19
20
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.6
9.7
69
269
S29
ICPC
Skin symptom/complaint other
1.4
9.7
448
3277
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
9.7
350
2435
R1250
NOMESCO Finland
Evaluation of functional capability
2.6
9.7
66
253
H02BX01
ATC
methylprednisolone, combinations; systemic
1.8
9.7
151
836
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.8
9.6
58
207
R03BB01
ATC
ipratropium bromide; inhalant
2.2
9.6
96
448
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.2
9.6
93
428
A05
ICPC
Feeling ill
1.9
9.6
141
768
XJC00
NOMESCO Finland
Oesophageal manometry
6.4
9.5
24
38
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
9.5
66
256
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.9
9.5
138
743
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.2
9.5
97
455
M01AH03
ATC
valdecoxib; oral
1.7
9.5
182
1075
D69.0
ICD-10 Finland
Allergic purpura
5.2
9.5
28
54
K75.4
ICD-10 Finland
Autoimmune hepatitis
9.1
9.5
19
21
SPF50
NOMESCO Finland
Removal and reattachment with cement of tooth bridnge
6.0
9.5
25
42
R01AD05
ATC
budesonide; nasal
1.6
9.5
225
1413
A08
ICPC
Swelling
2.0
9.5
122
632
R06AX26
ATC
fexofenadine; oral
1.7
9.4
192
1159
M35.2
ICD-10 Finland
Behçet disease
100.3
9.4
10
*
D01
ICPC
Abdominal pain/cramps general
1.5
9.4
287
1924
RT272
NOMESCO Finland
NA
6.6
9.4
23
35
L50.3
ICD-10 Finland
Dermatographic urticaria
2.9
9.4
56
198
TQW80
NOMESCO Finland
Local dermatologic skincare
2.4
9.4
75
314
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.4
476
3543
L01AA01
ATC
cyclophosphamide; systemic
12.4
9.3
16
13
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.4
9.3
16
13
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.1
9.3
98
465
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.4
9.3
74
309
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
6.9
9.3
22
32
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
9.3
300
2037
L86
ICPC
Back syndrome with radiating pain
1.8
9.3
155
878
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
4.5
9.2
31
69
H53.2
ICD-10 Finland
Diplopia
2.3
9.2
85
382
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.3
9.2
79
342
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.1
9.2
105
519
H26.3
ICD-10 Finland
Drug-induced cataract
5.5
9.2
26
48
A06AC51
ATC
ispaghula, combinations; systemic
1.8
9.2
145
806
R49.08
ICD-10 Finland
Other specified dysphonia
2.4
9.2
74
312
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
9.2
151
854
J01CA08
ATC
pivmecillinam; oral
1.3
9.2
1390
12129
R11
ICD-10 Finland
Nausea and vomiting
1.7
9.2
206
1279
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
9.2
145
808
S06.0
ICD-10 Finland
Concussion
1.6
9.2
248
1613
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
9.1
849
6949
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
9.1
456
3382
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
4.0
9.1
35
89
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
9.1
127
677
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
3.9
9.1
36
94
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
5.1
9.1
27
53
L04AB05
ATC
certolizumab pegol; parenteral
5.9
9.0
24
41
M60.9
ICD-10 Finland
Myositis, unspecified
5.9
9.0
24
41
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
9.0
9.0
18
20
A02BB01
ATC
misoprostol; oral
4.7
9.0
29
62
WZC30
NOMESCO Finland
Teaching
1.5
9.0
335
2346
XF402
NOMESCO Finland
ECG with work load test
1.5
9.0
272
1821
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
9.0
380
2732
-50
ICPC
Medication/prescr/renewal
2.0
9.0
112
574
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
9.0
228
1463
A07DA03
ATC
loperamide; oral
2.1
8.9
98
476
S02.51
ICD-10 Finland
Fracture of tooth, open
1.6
8.9
265
1763
F03
ICPC
Eye discharge
1.7
8.9
170
1006
6BA02
NOMESCO Finland
NA
7.4
8.9
20
27
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
24.1
8.9
12
5
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.6
8.9
62
242
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.6
8.9
29
63
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.1
8.9
95
456
C08CA13
ATC
lercanidipine; oral
1.5
8.9
335
2353
M03BX01
ATC
baclofen; systemic
2.9
8.9
52
182
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
8.9
198
1227
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.8
8.9
146
824
S97
ICPC
Chronic ulcer skin
1.9
8.8
129
700
D06
ICPC
Abdominal pain localized other
1.6
8.8
225
1445
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.6
8.8
204
1277
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.6
8.8
218
1386
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
8.8
387
2800
R06.2
ICD-10 Finland
Wheezing
2.0
8.8
110
562
D01AE16
ATC
amorolfine; topical
1.5
8.8
310
2149
NF1DA
NOMESCO Finland
X-ray of hips
2.4
8.8
70
292
NH3AE
NOMESCO Finland
Feet ultrasound examination
6.3
8.8
22
35
X58
ICD-10 Finland
Exposure to other specified factors
1.5
8.7
311
2159
L16
ICPC
Ankle symptom/complaint
1.5
8.7
269
1806
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
2.7
8.7
56
208
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
8.7
141
791
M01AB01
ATC
indometacin; systemic, rectal
1.7
8.7
168
998
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
8.7
109
557
R55
ICD-10 Finland
Syncope and collapse
1.6
8.7
255
1693
D84.18
ICD-10 Finland
Other specified defect in the complement system
50.1
8.7
10
*
7230B
ICD-9 Finland
Other disorders of cervical region, Spinal stenosis of cervical region[SUBLUXATIO ATLANTO-AXIALIS]
50.1
8.7
10
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.8
8.7
55
202
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.4
8.6
72
307
ND1AE
NOMESCO Finland
Wrist ultrasound examination
7.6
8.6
19
25
K04.1
ICD-10 Finland
Necrosis of pulp
1.6
8.6
253
1681
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.4
8.6
67
278
K13.00
ICD-10 Finland
Cheilitis NOS
6.1
8.6
22
36
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
2.6
8.6
62
244
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
5.8
8.6
23
40
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.0
8.6
46
153
NHG82
NOMESCO Finland
Fusion of other tarsal joint
3.2
8.5
43
137
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
8.5
262
1757
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
9.0
8.5
17
19
S09
ICPC
Infected finger/toe
2.2
8.5
83
385
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
8.5
235
1541
K11.84
ICD-10 Finland
Sialos
27.6
8.5
11
*
H92.0
ICD-10 Finland
Otalgia
1.8
8.5
139
784
N03AF02
ATC
oxcarbazepine; oral
2.2
8.5
82
377
M81.8
ICD-10 Finland
Other osteoporosis
4.0
8.4
32
81
SPAT1211
SPAT
Application of soft bandage
1.6
8.4
228
1486
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
3.8
8.4
34
91
N06AA12
ATC
doxepin; systemic
1.7
8.4
158
930
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.3
8.4
71
307
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
8.4
326
2306
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
8.3
98
490
ZZH31
NOMESCO Finland
Bone allograft, small pieces
3.5
8.3
37
107
R03BC03
ATC
nedocromil; inhalant
1.6
8.3
207
1318
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
8.3
8
*
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
8.3
8
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.2
8.3
42
134
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.2
8.3
82
382
L02
ICPC
Back symptom/complaint
1.6
8.3
239
1582
NCM20
NOMESCO Finland
Excision of synovial ganglion of elbow or forearm
8.5
8.3
17
20
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.0
8.3
46
157
M54.8
ICD-10 Finland
Other dorsalgia
1.9
8.3
110
575
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
8.3
128
709
9289
FHL
Other measure in this category
9.5
8.3
16
17
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.0
8.3
95
471
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
8.3
76
343
ECA20
NOMESCO Finland
Biopsy of gingiva
3.1
8.2
42
135
G01AF05
ATC
econazole; vaginal
1.5
8.2
275
1881
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
7.1
8.2
19
27
S01
ICPC
Pain/tenderness of skin
1.9
8.2
118
636
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.6
8.2
35
98
L19
ICPC
Muscle symptom/complaint NOS
2.3
8.2
70
304
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.5
8.2
63
257
J37.0
ICD-10 Finland
Chronic laryngitis
2.1
8.2
93
460
VALMI
NOMESCO Finland
NA
1.3
8.2
633
5036
R63.4
ICD-10 Finland
Abnormal weight loss
2.1
8.2
88
425
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.5
8.2
63
258
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
6.5
8.2
20
31
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
6.5
8.2
20
31
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
8.2
158
941
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
4.1
8.1
30
74
WX204
NOMESCO Finland
Axillary plexus blockaced
2.1
8.1
90
440
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.4
8.1
66
279
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
8.1
145
841
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
8.1
581
4568
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.6
8.1
206
1321
7199X
ICD-9 Finland
Other and unspecified disorder of joint, Unspecified disorder of joint[MB ARTICULI NUD,MÄÄRITTELEMÄTÖN]
17.2
8.1
12
7
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
8.1
80
374
SPAT1131
SPAT
Colonoscopy
2.1
8.0
91
447
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
4.0
8.0
30
75
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
8.9
8.0
16
18
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.8
8.0
32
85
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
8.0
168
1021
D10AX03
ATC
azelaic acid; topical
1.7
8.0
168
1021
K03.2
ICD-10 Finland
Erosion of teeth
2.5
8.0
59
238
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
8.0
1130
9728
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.1
8.0
82
390
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.9
8.0
110
587
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
7.9
226
1492
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.7
7.9
169
1038
R96
ICPC
Asthma
1.5
7.9
243
1633
AN1
HP
Coronary angiography
1.5
7.9
243
1636
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.3
7.9
67
290
N99
ICPC
Neurological disease other
3.5
7.8
34
97
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.3
7.8
71
319
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
7.8
99
512
D02
ICPC
Abdominal pain epigastric
1.7
7.8
155
931
S06
ICPC
Rash localized
1.7
7.8
151
897
S08
ICPC
Skin colour change
1.8
7.8
128
724
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
7.8
153
916
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
2.9
7.8
45
156
M01CC01
ATC
penicillamine; oral
8.5
7.8
16
19
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.4
7.8
36
108
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.3
7.8
72
323
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
7.8
624
4989
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.5
7.8
232
1549
SPF30
NOMESCO Finland
Soling for prothesis
2.5
7.8
57
227
SBA20
NOMESCO Finland
Measurement of buffering capacity of saliva
9.4
7.8
15
16
K14.60
ICD-10 Finland
Glossopyrosis
4.1
7.8
28
68
L18
ICPC
Muscle pain
1.9
7.8
102
533
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.9
7.8
104
547
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
7.0
7.8
18
26
K11.88
ICD-10 Finland
Other diseases of salivary glands
7.0
7.8
18
26
C09CA01
ATC
losartan; oral
1.3
7.8
603
4800
L15
ICPC
Knee symptom/complaint
1.3
7.8
574
4536
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
4.8
7.7
24
50
M01AC01
ATC
piroxicam; systemic, rectal
1.4
7.7
358
2615
N06AX17
ATC
milnacipran; oral
3.0
7.7
42
142
M43.1
ICD-10 Finland
Spondylolisthesis
1.9
7.7
114
623
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
15.0
7.7
12
8
SXC04
NOMESCO Finland
Other oral or dental procedure, extensive
15.0
7.7
12
8
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
5.0
7.7
23
46
N06AA06
ATC
trimipramine; systemic
2.2
7.7
77
361
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
5.6
7.7
21
38
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
7.4
7.7
17
23
L04
ICPC
Chest symptom/complaint
1.7
7.7
148
882
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.7
7.7
160
976
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.9
7.7
103
542
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
7.6
178
1118
G01AF02
ATC
clotrimazole; vaginal
1.8
7.6
128
727
N06AX03
ATC
mianserin; oral
1.8
7.6
135
781
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.8
7.6
119
665
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.9
7.6
109
590
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.2
7.6
37
116
NDC40
NOMESCO Finland
Secondary prosthetic replacement in of joint of finger or metacarpal
8.0
7.6
16
20
SFC00
NOMESCO Finland
Pillar of fillings material
2.1
7.6
78
369
R28
ICPC
Limited function/disability (R)
3.1
7.5
38
122
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.1
7.5
22
43
K07.24
ICD-10 Finland
Open bite
3.8
7.5
30
80
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
7.5
178
1121
XG405
NOMESCO Finland
Education on PEF monitoring
2.8
7.5
46
168
KCV04
NOMESCO Finland
Distension of bladder with fluid
3.1
7.5
39
128
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.8
7.5
134
777
H01
ICPC
Ear pain/earache
1.5
7.5
263
1820
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.5
87
435
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.8
7.5
112
617
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
7.4
271
1890
K02.9
ICD-10 Finland
Dental caries, unspecified
2.9
7.4
43
150
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.3
7.4
67
299
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.2
7.4
68
308
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.0
7.4
40
135
NBF15
NOMESCO Finland
Humeroscapular synovectomy, arthroscopic
6.5
7.4
18
28
SCB02
NOMESCO Finland
Training for mouth care at home
6.5
7.4
18
28
H15.0
ICD-10 Finland
Scleritis
6.5
7.4
18
28
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
2.1
7.4
82
402
B01AA03
ATC
warfarin; systemic
1.4
7.4
408
3076
J34.2
ICD-10 Finland
Deviated nasal septum
1.9
7.4
103
551
9284
FHL
Wrist ossification surgery
7.7
7.4
16
21
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.7
7.4
47
173
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.8
7.4
111
611
SPB06
NOMESCO Finland
Production of temporary clinic-made tooth- or implant-retained crown or bridge unit
5.3
7.4
21
40
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
6.0
7.4
19
32
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
5.6
7.4
20
36
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
7.3
306
2194
E06.3
ICD-10 Finland
Autoimmune thyroiditis
3.9
7.3
28
72
ZX100
NOMESCO Finland
Oral
2.9
7.3
43
152
-31
ICPC
Medical examin/health eval partial
1.6
7.3
176
1114
N76.2
ICD-10 Finland
Acute vulvitis
4.7
7.3
23
49
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
7.3
7
*
H18.8
ICD-10 Finland
Other specified disorders of cornea
4.2
7.3
26
63
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
3.2
7.3
35
109
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.1
7.3
37
120
M01AB16
ATC
aceclofenac; oral
2.0
7.2
92
477
NDG74
NOMESCO Finland
Fusion of first IP joint
5.1
7.2
21
41
K10.3
ICD-10 Finland
Alveolitis of jaws
1.9
7.2
102
551
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.1
7.2
37
121
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
7.2
308
2221
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.6
7.2
23
50
G01AF04
ATC
miconazole; vaginal
1.6
7.2
165
1033
J01DC02
ATC
cefuroxime; systemic
1.7
7.2
150
913
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
7.2
133
783
U05
ICPC
Urination problems other
1.8
7.2
111
616
N06AX12
ATC
bupropion; oral
1.7
7.2
135
800
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.3
7.2
34
105
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
7.1
150
917
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
4.8
7.1
22
46
K29
ICPC
Cardiovascular sympt/complt other
1.9
7.1
101
545
R03BB04
ATC
tiotropium bromide; inhalant
1.5
7.1
215
1440
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
6.6
7.1
17
26
L14
ICPC
Leg/thigh symptom/complaint
1.6
7.1
186
1202
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
6.0
7.1
18
30
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.7
7.1
154
950
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
7.1
170
1075
N03A
ATC
ANTIEPILEPTICS
8.8
7.0
14
16
SPA05
NOMESCO Finland
Guiding rail
8.8
7.0
14
16
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
8.8
7.0
14
16
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
7.0
181
1168
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.2
7.0
65
296
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.7
7.0
43
158
107
Kela drug reimbursment
Pernicious anaemia
2.4
7.0
56
237
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.8
7.0
42
152
K14.61
ICD-10 Finland
Glossodynia
3.4
7.0
31
91
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
7.0
257
1797
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.9
7.0
40
138
SPAT1104
SPAT
Monitoring of emergency patient
1.6
7.0
155
963
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.6
7.0
174
1114
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
4.9
7.0
21
43
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.9
6.9
40
139
D82
ICPC
Teeth/gum disease
1.3
6.9
862
7282
K03.28
ICD-10 Finland
Other erosion of teeth
2.9
6.9
40
140
N03AX11
ATC
topiramate; oral
2.2
6.9
67
312
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.2
6.9
24
57
S21
ICPC
Skin texture symptom/complaint
1.4
6.9
304
2202
L05
ICPC
Flank/axilla symptom/complaint
1.7
6.9
136
818
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.5
6.9
243
1683
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
7.5
6.9
15
20
R25.2
ICD-10 Finland
Cramp and spasm
2.2
6.9
64
292
M77.9
ICD-10 Finland
Enthesopathy, unspecified
2.1
6.9
72
347
J45
ICD-10 Finland
Asthma
1.5
6.9
257
1802
R31
ICD-10 Finland
Unspecified haematuria
1.6
6.9
176
1132
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.3
6.9
61
272
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.6
6.9
46
178
N30.2
ICD-10 Finland
Other chronic cystitis
3.1
6.8
34
109
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.6
6.8
48
189
5BA08
NOMESCO Finland
NA
4.8
6.8
21
44
L50.0
ICD-10 Finland
Allergic urticaria
2.1
6.8
69
328
7199L
ICD-9 Finland
Other and unspecified disorder of joint, Unspecified disorder of joint[MB ARTICULI NUD,USEAT NIVELET]
10.9
6.8
12
11
E23.03
ICD-10 Finland
Lack of ACTH
10.9
6.8
12
11
M81.4
ICD-10 Finland
Drug-induced osteoporosis
5.0
6.8
20
40
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.3
6.8
58
255
N06AB08
ATC
fluvoxamine; oral
2.0
6.8
78
391
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.0
6.8
25
63
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
3.7
6.8
27
73
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.2
6.7
66
309
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
2.8
6.7
41
150
SPAT1284
SPAT
Extensive health certificate
2.1
6.7
70
334
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.8
6.7
113
645
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.7
6.7
44
167
S22.3
ICD-10 Finland
Fracture of rib
1.7
6.7
129
768
UJF92
NOMESCO Finland
Capsular endoscopy
2.5
6.7
51
210
R05DA01
ATC
ethylmorphine; oral
1.5
6.7
215
1457
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.8
6.7
40
144
G04AC01
ATC
NA
1.9
6.7
96
521
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.7
2590
24731
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.0
6.7
79
398
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.7
6.7
21
45
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
6.7
285
2051
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.8
6.7
105
586
S22
ICPC
Nail symptom/complaint
1.7
6.7
139
849
M06
ICD-10 Finland
Other rheumatoid arthritis
4.1
6.7
24
59
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
2.2
6.7
60
270
NDG63
NOMESCO Finland
Arthroplasty of II-V MCP joint
22.6
6.7
9
*
N05BE01
ATC
buspirone; oral
2.1
6.7
70
338
G04CA02
ATC
tamsulosin; oral
1.5
6.7
220
1503
SPAT1202
SPAT
Intra-articular injection
1.9
6.6
95
513
M51.2
ICD-10 Finland
Other specified intervertebral disc displacement
4.4
6.6
22
50
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
6.6
327
2416
K03.0
ICD-10 Finland
Excessive attrition of teeth
2.0
6.6
81
415
-
ICD-10 Finland
NA
2.1
6.6
70
339
RS221
NOMESCO Finland
NA
2.7
6.6
41
152
G04CA01
ATC
alfuzosin; oral
1.8
6.6
110
625
R03DC01
ATC
zafirlukast; oral
2.5
6.6
50
205
L53.9
ICD-10 Finland
Erythematous condition, unspecified
2.9
6.6
38
132
M15.3
ICD-10 Finland
Secondary multiple arthrosis
5.9
6.6
17
29
M12.3
ICD-10 Finland
Palindromic rheumatism
5.9
6.6
17
29
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
5.9
6.6
17
29
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.9
6.6
95
517
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.1
6.6
69
331
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
6.6
170
1097
RF210
NOMESCO Finland
NA
2.0
6.6
76
380
ULA02
NOMESCO Finland
Kolposcopy
1.4
6.6
267
1903
-69
ICPC
Other reason for encounter NEC
1.8
6.6
101
563
9260
FHL
Alloarthroplasty, endoprosthesis or implant
12.3
6.6
11
9
RS121
NOMESCO Finland
NA
4.0
6.6
24
60
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
6.6
222
1526
I77.6
ICD-10 Finland
Arteritis, unspecified
8.7
6.5
13
15
N81.6
ICD-10 Finland
Rectocele
1.5
6.5
223
1533
F73
ICPC
Eye infection/inflammation other
2.4
6.5
51
215
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
6.5
67
321
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
10.0
6.5
12
12
U07
ICPC
Urine symptom/complaint other
1.6
6.5
152
957
NDG76
NOMESCO Finland
Fusion of DIP joint
3.0
6.5
35
119
R5599
NOMESCO Finland
Other rehabilitation service
2.0
6.5
73
361
M17.5
ICD-10 Finland
Other secondary gonarthrosis
2.7
6.5
40
148
XJC10
NOMESCO Finland
Oesophageal pH monitoring
4.1
6.5
23
56
R09
ICPC
Sinus symptom/complaint
1.5
6.5
205
1388
N80.0
ICD-10 Finland
Endometriosis of uterus
2.1
6.5
69
336
G03CC04
ATC
estrone; systemic
1.8
6.5
111
641
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
6.5
94
514
P06
ICPC
Sleep disturbance
1.5
6.5
232
1613
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
6.5
75
376
EHA10
NOMESCO Finland
Biopsy of palate
3.7
6.5
26
71
NC1CG
NOMESCO Finland
Elbow and forearm extensive MRI examination with high intensity magnet
6.2
6.5
16
26
Z00.8
ICD-10 Finland
Other general examinations
1.6
6.4
170
1104
N06AX05
ATC
trazodone; oral
2.1
6.4
68
328
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.4
6.4
49
203
J20
ICD-10 Finland
Acute bronchitis
1.5
6.4
244
1716
M01AE52
ATC
naproxen and esomeprazole; oral
1.8
6.4
95
521
L50.8
ICD-10 Finland
Other urticaria
2.3
6.4
55
243
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.8
6.3
38
138
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.3
6.3
55
244
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
6.3
172
1125
A07AA09
ATC
vancomycin; oral
3.0
6.3
33
110
L71.0
ICD-10 Finland
Perioral dermatitis
2.5
6.3
45
179
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
6.3
145
907
R4190
NOMESCO Finland
Nutritional therapy
2.0
6.3
74
373
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
6.3
1824
16784
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
6.0
6.3
16
27
XQ848
NOMESCO Finland
Dermatological photography
2.1
6.3
67
325
M25.9
ICD-10 Finland
Joint disorder, unspecified
3.2
6.3
30
94
S20
ICPC
Corn/callosity
2.4
6.3
49
207
J38.7
ICD-10 Finland
Other diseases of larynx
4.6
6.3
20
44
K11.69
ICD-10 Finland
Mukocele UNS
4.6
6.3
20
44
K94
ICPC
Phlebitis/thrombophlebitis
2.6
6.3
41
156
XX1VW
NOMESCO Finland
Written report from radiologist
3.8
6.3
24
63
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.3
6.3
29
89
M35.4
ICD-10 Finland
Diffuse (eosinophilic) fasciitis
+∞
6.2
6
*
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
6.2
6
*
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
6.2
6
*
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
6.2
6
*
EBA40
NOMESCO Finland
Excision of apex of root of tooth
2.7
6.2
39
146
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
6.2
146
921
Y0609
ICD-8 Finland
Examination of the urinary and genital organs, Genital organs
2.4
6.2
51
219
WX722
NOMESCO Finland
PEEP
1.8
6.2
98
551
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
26.7
6.2
8
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.4
6.2
28
84
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.3
6.2
51
220
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.0
6.2
71
355
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
6.2
203
1385
R23
ICPC
Voice symptom/complaint
2.2
6.2
59
273
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.5
6.2
178
1182
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
6.2
57
261
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.7
6.2
40
150
R29
ICPC
Respiratory symptom/complaint other
1.6
6.2
156
1001
N06AX22
ATC
agomelatine; oral
2.3
6.2
53
232
K14.69
ICD-10 Finland
Tongue pain UNS
3.8
6.2
24
64
6253A
ICD-9 Finland
Pain and other symptoms associated with female genital organs, Dysmenorrhoea
3.8
6.2
24
64
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
6.3
6.2
15
24
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.8
6.2
91
499
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
6.1
351
2661
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.3
6.1
28
85
N30.8
ICD-10 Finland
Other cystitis
3.3
6.1
28
85
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
3.1
6.1
30
96
A07EA06
ATC
budesonide; oral, local oral
1.9
6.1
81
428
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
2.9
6.1
33
113
M05.0
ICD-10 Finland
Felty syndrome
7.7
6.1
13
17
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
7.7
6.1
13
17
S07
ICPC
Rash generalized
4.2
6.1
21
50
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
12.5
6.1
10
8
QDH
NOMESCO Finland
Operations on toe nails
12.5
6.1
10
8
XCH00
NOMESCO Finland
Eye pressure measurement
1.8
6.1
100
571
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
6.1
342
2587
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.9
6.1
35
123
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
2.9
6.1
35
123
M25.2
ICD-10 Finland
Flail joint
2.9
6.1
35
123
M15
ICD-10 Finland
Polyarthrosis
1.6
6.1
139
871
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
8.6
6.0
12
14
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
2.6
6.0
40
154
JAH01
NOMESCO Finland
Laparoscopy
1.7
6.0
119
716
H16.8
ICD-10 Finland
Other keratitis
6.7
6.0
14
21
D19
ICPC
Teeth/gum symptom/complaint
1.3
6.0
657
5452
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004616) Nuclear Ab [Presence] in Serum
328
289
12.46
320.65
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2609
14466
4.48
318.20
10.3
5.4
e9/l
1.7
1.9
16.18
2477
12659
(3038026) Centromere Ab [Units/volume] in Serum
274
180
16.47
317.64
1.5
1.1
u/ml
22.9
49.9
—
24
7
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1010
1062
13.12
307.65
1.6
1.2
u/ml
5.9
0.7
4.50
70
101
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
685
482
17.55
307.65
1.5
1.1
u/ml
9.0
0.5
—
29
6
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1028
601
24.11
307.65
1.7
1.1
u/ml
4.7
2.1
1.90
294
41
(3006315) Basophils [#/volume] in Blood
2594
14134
4.55
307.65
10.2
5.4
e9/l
0.0
0.0
6.91
2435
12121
(3013293) Extractable nuclear Ab [Presence] in Serum
207
17
129.61
307.65
1.6
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
990
718
19.06
307.65
2.6
1.3
g/l
1.1
1.2
12.65
969
681
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
995
691
19.96
307.65
2.6
1.2
g/l
0.2
0.2
28.89
963
656
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1033
612
23.83
307.65
1.7
1.1
u/ml
4.2
3.7
0.18
390
78
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
847
473
23.53
307.65
1.6
1.1
u/ml
3.1
4.5
0.18
146
27
(3037522) Nuclear Ab [Titer] in Serum
1619
3740
7.37
307.65
1.8
1.3
titre
1186.1
394.4
41.59
824
730
(3028026) IgM [Mass/volume] in Serum or Plasma
721
1544
5.66
307.65
2.0
1.8
g/l
1.3
1.4
0.36
668
1398
(3013115) Eosinophils [#/volume] in Blood
2641
14658
4.62
307.65
10.4
5.6
e9/l
0.2
0.2
11.10
2493
12787
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
859
515
22.00
307.65
1.6
1.1
u/ml
75.9
26.8
8.39
200
50
(3005719) IgG [Mass/volume] in Serum or Plasma
944
1966
6.27
307.65
3.6
2.6
g/l
12.6
10.4
23.25
875
1782
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
880
746
15.58
307.65
2.7
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
580
281
24.69
307.65
1.6
1.1
u/ml
38.0
36.3
0.02
59
11
(3001604) Monocytes [#/volume] in Blood
2593
14068
4.58
307.65
10.2
5.4
e9/l
0.5
0.6
4.10
2435
12067
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1069
681
22.46
307.65
1.7
1.1
u/ml
54.3
12.1
6.94
286
30
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1391
5252
3.79
299.40
1.5
1.3
iu/ml
81.5
32.8
4.23
685
1629
(3023420) DNA double strand Ab [Units/volume] in Serum
306
276
12.09
294.27
2.4
1.1
iu/ml
34.5
23.4
—
24
7
(3022096) Basophils/100 leukocytes in Blood
2360
12804
3.77
282.55
10.5
5.6
%
0.7
0.7
0.95
2261
11862
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
252
179
15.13
279.68
1.5
1.1
u/ml
65.9
61.9
—
86
9
(3006504) Eosinophils/100 leukocytes in Blood
2396
13206
3.77
278.00
10.4
5.5
%
2.8
2.8
0.02
2301
12228
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
245
168
15.64
277.18
1.5
1.1
u/ml
7.8
3.6
—
47
9
(3019069) Monocytes/100 leukocytes in Blood
2402
13286
3.77
276.55
10.8
5.8
%
9.2
8.4
25.94
2310
12371
(42870588) Differential panel, method unspecified - Blood
1951
9530
3.47
273.46
9.2
5.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2732
16655
4.29
266.56
12.4
8.9
e9/l
3.7
4.0
12.02
2557
14496
(3002030) Lymphocytes/100 leukocytes in Blood
2417
13639
3.69
264.65
10.7
5.6
%
28.5
28.5
0.05
2316
12627
(3018010) Neutrophils/100 leukocytes in Blood
2389
13450
3.63
261.01
10.3
5.4
%
56.6
56.8
0.49
2291
12495
(40759836) Histone Ab [Presence] in Serum by Immunoblot
236
173
14.59
257.10
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
236
173
14.59
257.10
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
236
174
14.50
256.25
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
236
175
14.42
255.40
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
236
175
14.42
255.40
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
236
175
14.42
255.40
1.3
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1257
5011
3.40
239.19
1.4
1.3
u/ml
24.3
12.3
2.95
503
1931
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
239
204
12.53
237.47
2.3
1.8
mg/l
3.0
4.1
2.63
229
198
(3007164) IgA [Mass/volume] in Serum or Plasma
1312
5632
3.17
216.71
1.9
1.4
g/l
2.6
2.3
6.00
892
3305
(3013707) Erythrocyte sedimentation rate by Westergren method
3039
21922
4.71
189.77
9.2
3.8
mm/h
15.5
12.6
20.42
2931
20198
(3004588) Protein electrophoresis panel - Serum or Plasma
619
1793
4.00
187.18
1.9
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1301
6140
2.82
173.31
6.6
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1601
8499
2.67
167.61
2.7
2.0
u/l
120.7
188.4
5.16
1526
7924
(3037467) Urinalysis macro (dipstick) panel - Urine
2813
20088
3.35
160.09
7.4
4.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
654
2178
3.48
159.01
2.0
2.7
g/l
69.5
66.5
16.18
593
1974
(3035350) Ketones [Presence] in Urine by Test strip
2217
14169
2.63
152.57
5.8
3.8
estimate
0.0
0.0
0.00
538
2520
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3001
22592
3.85
149.95
11.1
7.3
u/l
74.5
78.2
6.93
2897
21116
(3021601) Nitrite [Presence] in Urine by Test strip
2222
14283
2.61
149.93
7.5
5.1
estimate
0.0
0.0
0.50
553
2531
(3009261) Glucose [Presence] in Urine by Test strip
2236
14428
2.61
149.46
5.9
3.8
estimate
0.0
0.0
1.32
551
2531
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
343
770
4.84
143.21
1.7
1.5
titre
351.9
288.1
0.14
27
27
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2063
12974
2.51
143.09
2.8
2.2
nmol/l
83.5
79.3
9.75
1922
11608
(3017181) Myelocytes/100 leukocytes in Blood
649
2320
3.22
139.31
4.6
3.8
%
0.8
0.9
0.30
165
605
(3021440) Promyelocytes/100 leukocytes in Blood
626
2205
3.26
137.61
4.7
3.8
%
0.1
0.1
0.62
149
548
(3025159) Blasts/100 leukocytes in Blood
596
2074
3.27
133.40
4.7
3.8
%
0.5
0.6
0.01
134
465
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
120
88
14.10
130.02
1.1
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
594
2117
3.19
127.36
4.2
3.6
%
0.4
0.6
1.64
112
430
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2205
14778
2.41
125.39
7.1
6.2
mmol/l
1.2
1.2
2.24
1856
12402
(3024980) IgG subclass 4 [Mass/volume] in Serum
231
412
5.94
124.55
1.6
1.5
g/l
0.6
0.7
0.18
162
311
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1261
6727
2.39
120.96
1.4
1.3
u/ml
2.3
1.7
0.70
356
1787
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2039
13377
2.31
119.33
6.3
5.5
mmol/l
1.2
1.2
3.19
1881
12005
(3018418) pH of Serum or Plasma
1492
8881
2.21
106.99
4.0
3.9
ph
7.4
7.4
0.97
299
1645
(3021589) Normoblasts [#/volume] in Blood
1922
12674
2.19
105.97
14.1
9.0
e9/l
0.0
0.0
0.15
1725
10291
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
375
1139
3.58
102.92
2.0
2.0
u/l
40.0
40.1
0.01
342
1012
(4062490)
163
255
6.66
99.96
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1589
9903
2.14
99.12
5.0
3.5
e6/l
57.7
106.5
3.93
1190
6778
(3024139) IgG subclass 3 [Mass/volume] in Serum
159
251
6.60
96.65
1.6
1.4
g/l
0.4
0.4
0.08
104
179
(3028192) IgG subclass 2 [Mass/volume] in Serum
159
251
6.60
96.65
1.6
1.4
g/l
2.8
2.8
0.01
104
180
(3027135) IgG subclass 1 [Mass/volume] in Serum
159
252
6.57
96.27
1.6
1.4
g/l
8.5
6.9
1.92
104
180
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
115
126
9.41
95.49
1.9
1.2
u/l
5.8
5.6
0.09
96
107
(3000850) Epithelial cells [#/volume] in Urine
1065
5763
2.24
94.17
3.4
2.4
e6/l
5.1
7.1
5.02
955
5014
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
233
534
4.61
94.08
3.2
3.4
%
57.2
57.3
0.04
233
534
(3029937) Albumin [Presence] in Urine by Test strip
1284
7554
2.13
91.18
6.6
4.2
estimate
0.0
0.0
1.28
556
2521
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
268
707
4.03
89.93
1.9
2.1
mg/l
10.5
11.7
1.25
250
648
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
247
617
4.24
89.22
1.6
1.2
iu/ml
29.1
5.1
—
7
6
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
330
1033
3.43
85.96
1.8
2.5
g/l
7.3
7.5
0.99
257
771
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
330
1033
3.43
85.96
1.8
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
329
1031
3.43
85.54
1.8
2.5
g/l
3.7
3.7
0.07
245
732
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
318
977
3.49
85.28
1.8
2.6
g/l
3.0
3.1
1.21
252
750
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1208
7109
2.09
84.23
2.6
2.2
mg/l
3.0
3.0
0.11
1049
6061
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1846
12649
2.01
83.96
3.4
2.8
ug/l
119.3
108.1
0.87
1700
11684
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1650
10906
2.00
82.79
6.3
4.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1336
8266
2.02
80.23
4.3
3.0
e6/l
44.4
67.1
0.53
1110
6213
(3024561) Albumin [Mass/volume] in Serum or Plasma
1830
12641
1.97
79.73
4.7
4.5
g/l
35.5
35.6
0.37
1696
11688
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
304
959
3.38
78.03
1.6
2.6
g/l
12.4
10.1
7.76
262
796
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
268
781
3.64
77.74
1.9
2.5
g/l
0.0
0.0
0.88
244
717
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1284
7906
2.00
77.52
3.1
2.9
ng/l
912.9
1207.4
3.21
1103
6715
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
290
892
3.46
77.45
1.9
2.6
g/l
0.5
0.9
2.06
253
768
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
65
42
15.76
75.25
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
65
42
15.76
75.25
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
65
42
15.76
75.25
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
65
42
15.76
75.25
1.2
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
259
754
3.64
75.20
1.3
1.2
titre
1347.6
742.9
1.11
21
24
(36304419) Bacteria [Presence] in Urine
1225
7489
2.00
74.89
4.0
2.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
584
2668
2.44
74.71
2.1
2.1
nmol/l
353.2
379.6
1.58
545
2425
(3007566) Smooth muscle Ab [Titer] in Serum
255
739
3.65
74.53
1.2
1.2
titre
200.4
90.2
0.94
25
43
(40768797) Stomach Pathology biopsy report
795
4189
2.17
72.28
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
806
4275
2.16
72.03
2.5
2.3
umol/l
12.8
13.1
0.55
746
3936
(3030467) Casts [#/volume] in Urine by Automated count
1239
7692
1.96
71.74
4.1
2.9
e6/l
0.2
0.5
7.39
1023
5712
(3011397) Hemoglobin [Presence] in Urine by Test strip
1128
6820
1.98
70.24
5.3
3.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
593
2814
2.34
69.21
1.5
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
169
382
4.60
69.21
1.4
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
749
3917
2.17
69.04
2.4
2.3
g/l
2.4
2.4
0.23
694
3610
(40758558) Short blood count panel - Blood
1202
7464
1.95
68.93
8.3
6.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
704
3599
2.21
68.67
2.5
2.4
%
21.9
22.4
0.32
620
3043
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
257
792
3.43
68.26
1.6
1.6
iu/ml
0.2
0.3
0.07
55
164
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
263
823
3.38
68.18
1.7
2.4
g/l
38.5
38.0
0.62
225
699
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
594
2866
2.30
66.47
3.2
4.2
u/l
236.3
247.5
1.17
568
2700
(3031040) Bacteria [#/volume] in Urine by Automated count
2466
19556
1.96
63.88
6.8
4.7
e6/l
2326.9
2520.2
0.06
50
237
(3037756) Immunofixation for Serum or Plasma
193
524
3.85
61.89
1.6
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2031
15238
1.83
61.41
6.1
6.1
umol/l
9.6
10.6
5.52
1929
14398
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1693
12140
1.79
58.42
2.2
2.0
pmol/l
99.3
97.3
0.87
828
5856
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
230
728
3.32
58.40
1.7
2.6
g/l
0.0
0.0
0.00
206
669
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2834
23894
2.13
57.78
5.7
4.4
pmol/l
14.9
14.8
2.85
2628
21751
(3041096) Erythrocytes [Presence] in Urine by Automated
1170
7583
1.83
56.09
5.5
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
900
5374
1.92
55.84
3.6
2.6
mosm/kgh2o
492.9
521.4
3.98
781
4557
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
157
396
4.11
55.72
1.3
1.2
u/ml
3.1
5.3
1.23
88
151
(3026493) Urate [Moles/volume] in Serum or Plasma
1102
7045
1.84
55.03
2.6
2.4
umol/l
2150.6
5080.5
2.32
934
6053
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
223
722
3.24
54.52
1.7
2.6
g/l
0.0
0.0
0.00
206
669
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3222
28915
3.28
54.33
23.7
13.3
mg/l
17.5
22.1
17.25
2775
22726
(3021960) Folate [Moles/volume] in Serum or Plasma
1062
6748
1.84
53.86
1.6
1.5
nmol/l
21.8
21.3
0.39
921
5694
(3015377) Calcium [Moles/volume] in Serum or Plasma
1497
10529
1.75
53.71
2.9
3.4
mmol/l
2.4
2.4
2.69
1312
9138
(3027945) Reticulocytes/100 erythrocytes in Blood
553
2838
2.13
52.12
3.0
2.4
%
1.7
1.8
3.25
498
2518
(3019309) Folate [Moles/volume] in Red Blood Cells
879
5325
1.88
51.53
2.0
1.7
nmol/l
1257.1
1183.3
1.55
691
3983
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1327
9134
1.74
50.49
2.8
2.5
u/l
57.7
57.3
0.13
1224
8382
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
153
409
3.87
50.09
1.3
1.2
u/ml
3.5
3.2
0.07
73
103
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
648
3582
2.00
49.72
1.5
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
400
1848
2.32
48.63
1.3
1.2
u/ml
137.3
175.4
0.67
353
1693
(46235355) HIV 1 and 2 tests - Meaningful Use set
707
4074
1.93
47.85
1.7
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
587
3177
2.03
47.61
2.1
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
785
4715
1.87
46.61
3.2
2.5
e6/l
1.1
1.3
0.86
527
2611
(40761535) Cells panel - Urine sediment
466
2349
2.14
45.60
5.3
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
388
1817
2.28
45.56
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
643
3645
1.94
45.46
2.0
2.1
ug/g
115.7
117.9
0.07
498
2830
(4268621)
116
272
4.38
45.30
2.1
2.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
223
804
2.90
45.12
2.0
2.3
ug/l
156.9
772.4
1.60
198
749
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
226
822
2.87
45.00
2.2
3.7
mg/l
38.1
45.5
0.39
180
674
(3000494) Fungus identified in Specimen by Culture
608
3403
1.96
44.54
1.7
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
225
822
2.86
44.43
2.3
3.7
mg/l
53.3
127.4
0.55
178
674
(3023368) Bacteria identified in Blood by Culture
1065
7088
1.73
44.36
5.2
4.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
151
437
3.57
44.00
1.7
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
157
470
3.45
43.44
1.7
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1466
10699
1.65
42.68
4.5
3.5
ng/l
396.1
38.5
0.58
991
7046
(3032080) INR in Blood by Coagulation assay
1509
11108
1.65
42.36
8.1
8.2
inr
1.2
1.2
1.07
503
3173
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
217
798
2.84
42.30
2.2
3.6
ratio
4.8
1.5
0.56
26
60
(3019150) Specific gravity of Urine by Refractometry
951
6217
1.74
41.76
6.5
4.3
kg/l
1.0
1.0
1.47
130
934
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3077
27575
2.25
41.61
6.9
5.2
mu/l
1.8
2.1
2.11
2883
25262
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
988
6543
1.72
41.33
1.9
1.7
mg/l
1.1
1.1
0.02
774
4973
(3011412) CD3 cells [#/volume] in Blood
101
230
4.50
40.94
2.4
2.2
e9/l
1.0
1.1
0.09
66
146
(3000475) Leukocytes [#/volume] in Synovial fluid
185
638
3.01
40.50
1.9
1.7
e6/l
21012.6
11308.4
0.66
148
464
(3023520) Reticulocytes [#/volume] in Blood
418
2114
2.11
40.29
2.5
2.5
e9/l
65.1
71.2
3.28
318
1588
(36660697) Celiac disease serology panel - Serum
466
2455
2.04
40.25
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
176
596
3.06
39.77
2.2
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
193
693
2.89
39.30
1.6
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
305
1386
2.32
38.21
1.2
1.1
titre
258.2
189.4
0.22
11
41
(3029075) Extractable nuclear Ab panel - Serum
54
72
7.61
38.21
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
426
2215
2.06
38.02
1.2
1.2
iu/ml
88.6
143.7
2.42
147
847
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
213
821
2.70
37.91
2.6
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2064
16688
1.60
37.47
5.2
4.3
mmol/l
6.2
6.6
23.07
1960
15566
(3017732) Neutrophils [#/volume] in Blood
394
2002
2.10
37.38
2.9
2.8
e9/l
3.7
4.0
1.04
289
1560
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
713
4415
1.78
37.25
2.1
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
113
301
3.85
37.18
1.7
1.5
%
53.0
57.8
0.60
71
188
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
946
6348
1.68
36.92
1.7
1.7
pmol/l
8915211.6
30785805.1
1.28
774
5246
(21494815) CD4 cells/100 lymphocytes in Specimen
87
192
4.62
36.67
1.9
2.1
%
41.9
38.9
—
9
22
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
83
178
4.75
36.22
2.2
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
443
2404
1.97
34.91
6.1
4.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
288
1339
2.26
34.09
1.2
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
93
230
4.13
33.90
1.7
1.5
%
34.2
36.1
0.17
53
140
(3045414) Leukocytes [Presence] in Urine
292
1369
2.24
33.87
2.1
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
97
249
3.98
33.62
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
621
3825
1.76
32.58
2.1
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
375
1992
1.99
31.26
2.5
2.4
au/ml
18.2
23.6
0.26
12
117
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
471
2706
1.86
31.01
2.4
2.1
g/l
0.2
0.2
0.13
440
2541
(3012095) Magnesium [Moles/volume] in Serum or Plasma
701
4522
1.69
30.96
2.9
3.2
mmol/l
0.8
0.8
1.00
643
4185
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
79
185
4.35
30.94
2.2
1.9
%
13.7
14.3
0.10
35
75
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
839
5679
1.63
30.72
2.8
3.0
mmol/l
2.5
2.5
0.31
733
4965
(3026008) Bacteria identified in Urine by Culture
1311
9866
1.54
30.25
4.2
3.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
153
566
2.78
29.45
2.0
2.2
g/l
126.7
127.5
0.15
96
408
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
46
69
6.74
29.31
1.8
1.4
ug/l
7.3
9.1
1.80
46
69
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
219
966
2.35
29.26
2.4
2.0
ug/l
1.3
2.1
0.65
197
850
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
77
185
4.24
29.19
1.2
1.1
titre
288.5
129.4
0.85
20
31
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
69
153
4.58
28.95
2.5
2.3
e6/l
392.9
526.9
1.16
57
128
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
60
119
5.11
28.71
1.2
1.1
u/ml
15.7
6.6
0.26
13
15
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1246
9354
1.52
28.66
3.7
3.2
u/l
32.0
33.1
0.35
1180
8862
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
340
1809
1.98
28.10
1.4
1.3
au/ml
26.4
40.2
—
8
87
(40768804) Tissue Pathology biopsy report
1596
12673
1.49
27.68
2.2
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
557
3473
1.72
27.57
4.7
5.1
mmol/l
1.0
1.0
0.29
510
3189
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
159
628
2.61
26.93
1.6
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
421
2446
1.82
26.51
3.7
3.7
mmol/l
1.2
1.2
1.27
364
2122
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
256
1258
2.12
26.26
1.1
1.1
u/ml
1.7
0.9
—
9
15
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
64
145
4.48
26.17
2.6
2.4
e9/l
0.2
0.2
0.07
56
126
(3042631) Mycobacterium sp identified in Specimen
107
347
3.15
26.06
2.9
2.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
57
118
4.90
25.99
1.6
1.3
%
6.4
3.9
0.46
13
24
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
232
1105
2.18
25.77
2.0
1.7
g/l
1.6
1.6
0.43
198
948
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
654
4334
1.63
25.46
3.5
2.7
e6/l
3.3
3.8
0.51
401
2250
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
125
452
2.83
25.13
1.5
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
88
259
3.46
25.05
1.3
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
105
351
3.06
24.30
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
126
469
2.75
24.00
2.7
4.9
iu/ml
1940.5
291.4
0.69
12
65
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
77
217
3.61
23.42
1.2
1.2
titre
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
135
531
2.61
23.07
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
149
623
2.46
22.42
1.7
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
63
160
3.99
22.23
2.8
2.5
e6/l
542.0
667.4
0.87
27
63
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
358
2093
1.79
21.91
1.7
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
357
2094
1.79
21.59
2.9
3.2
pmol/l
4.4
4.5
1.04
308
1869
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
398
2414
1.73
21.43
3.1
3.3
ng/l
76.9
82.9
0.68
339
2031
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
479
3055
1.66
21.39
1.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
480
3067
1.66
21.28
1.9
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
165
740
2.29
21.20
1.4
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
106
390
2.77
20.67
2.7
3.3
%
0.9
1.5
1.79
85
309
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
62
166
3.79
20.35
1.2
1.1
ratio
1.0
1.0
0.33
18
61
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
55
135
4.12
20.34
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
139
591
2.41
20.18
1.6
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
111
424
2.67
20.14
1.7
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
513
3377
1.61
20.10
1.3
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
603
4125
1.56
20.05
2.3
2.0
s
29.8
29.4
0.81
587
3999
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3233
30698
2.13
19.75
24.6
15.8
umol/l
72.5
72.0
0.40
3233
30689
(3019550) Sodium [Moles/volume] in Serum or Plasma
3173
29934
1.93
19.73
21.9
15.4
mmol/l
139.3
139.7
16.52
3120
29187
(3045424) Erythrocytes [Presence] in Urine
123
500
2.51
19.68
1.6
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
244
1309
1.93
19.55
3.3
2.6
e6/l
0.2
0.3
2.36
230
1265
(3023103) Potassium [Moles/volume] in Serum or Plasma
3178
30010
1.93
19.50
22.1
15.5
mmol/l
3.9
3.9
2.02
3125
29206
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
175
833
2.16
19.46
1.1
1.1
u/ml
6.7
5.3
0.17
16
100
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
64
181
3.58
19.42
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
94
336
2.85
19.37
1.5
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
137
593
2.37
19.12
2.9
3.1
mmol/l
25.1
25.3
0.18
127
517
(3008757) Leukocyte morphology finding [Identifier] in Blood
83
279
3.02
19.09
3.0
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
266
1483
1.86
18.94
4.0
3.4
mmol/l
1.8
2.0
0.51
200
1136
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2963
27481
1.62
18.86
18.8
12.6
ml/min/173m2
80.9
79.8
2.15
2634
22635
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
104
398
2.66
18.82
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
114
458
2.54
18.70
1.7
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3236
30800
2.10
18.62
17.9
10.3
u/l
24.6
24.4
0.42
3184
29673
(3033658) Prothrombin time (PT) actual/Normal
954
7272
1.43
18.39
4.0
3.6
%
93.9
93.6
0.15
921
7069
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2137
18657
1.39
18.35
3.7
3.0
u/l
47.9
44.6
0.94
1968
17247
(3009343) pH of Capillary blood
272
1543
1.83
18.31
4.1
3.4
ph
7.4
7.4
0.09
46
187
(3037121) Protein [Mass/volume] in Urine
186
928
2.06
18.30
2.8
3.1
g/l
0.4
0.3
0.82
69
323
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
274
1560
1.82
18.23
4.1
3.4
kpa
5.2
5.2
0.35
253
1446
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
41
87
4.76
18.21
1.9
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2638
23920
1.46
18.14
25.4
16.6
%
13.8
13.7
4.15
2613
23404
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
53
138
3.89
18.12
2.8
2.6
%
43.5
43.6
0.00
17
44
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
95
355
2.72
18.02
1.6
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
159
760
2.15
17.51
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
690
4985
1.48
17.50
1.5
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
158
755
2.15
17.42
1.7
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
95
362
2.67
17.36
1.3
1.3
pmol/l
252.5
371.2
0.83
76
292
(3008898) HLA-B27 [Presence]
190
974
2.01
17.36
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
119
507
2.40
17.23
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
44
104
4.27
17.13
1.9
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
116
491
2.41
17.05
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
151
720
2.15
16.74
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
45
111
4.10
16.58
1.2
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
46
116
4.01
16.46
1.6
2.2
%
146.5
131.3
0.47
46
109
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
87
326
2.71
16.45
1.3
1.1
u/l
55.3
55.5
0.01
64
233
(3011985) Renin [Units/volume] in Plasma
98
391
2.55
16.35
1.6
1.4
mu/l
52.0
38.2
0.45
89
353
(3023419) Bacteria identified in Sputum by Culture
88
333
2.69
16.32
2.7
2.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
345
2165
1.66
16.21
5.7
6.9
mmol/l
8.9
9.3
0.47
330
2061
(3013512) EKG study
1072
8488
1.38
16.16
4.3
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
102
421
2.47
15.85
2.8
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
84
325
2.62
14.94
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
121
553
2.23
14.93
3.2
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
502
3505
1.51
14.84
19.4
23.0
inr
1.2
1.3
0.31
70
480
(3044889) 12 lead EKG panel
2288
20510
1.36
14.69
4.4
3.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
69
243
2.88
14.69
3.8
3.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
144
710
2.07
14.66
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
70
249
2.85
14.63
1.5
1.4
e6/l
11898.8
104079.6
1.36
52
174
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
432
2930
1.54
14.61
3.6
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
174
921
1.94
14.52
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2015
17770
1.33
14.17
3.1
2.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
270
1645
1.70
14.16
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
174
933
1.91
13.98
1.4
1.4
ug/g
307.1
292.8
0.40
89
530
(3019225) pH of Specimen
439
3019
1.52
13.90
4.8
4.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
65
229
2.87
13.84
1.7
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
65
229
2.87
13.84
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
65
229
2.87
13.84
1.7
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
108
487
2.26
13.79
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
75
286
2.66
13.76
1.6
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
102
453
2.29
13.51
1.2
1.2
u/ml
290.5
285.1
0.07
72
274
(3028626) Oxygen [Partial pressure] in Capillary blood
111
512
2.21
13.43
2.8
2.7
kpa
8.2
8.2
0.18
105
467
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
344
2259
1.58
13.38
3.1
2.8
ng/l
172.9
177.9
0.07
307
2053
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
71
268
2.68
13.30
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2863
26770
1.45
13.23
5.9
5.6
mmol/mol
38.4
39.5
8.31
2672
24655
(3022621) pH of Urine by Test strip
307
1973
1.61
13.06
4.2
3.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
28
58
4.86
12.84
2.6
2.0
e6/l
138.8
121.9
0.16
17
32
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
30
66
4.58
12.81
2.7
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
154
818
1.92
12.75
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
114
543
2.14
12.74
2.5
2.4
%
15.9
16.1
0.14
67
259
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
344
2286
1.56
12.69
3.3
2.5
ml/min/173m2
63.1
65.6
0.74
157
921
(3032773) Endomysium IgG Ab [Titer] in Serum
65
241
2.73
12.62
1.2
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
143
745
1.96
12.54
3.5
2.4
g/l
3.6
3.6
0.07
136
703
(3017354) Segmented neutrophils/100 leukocytes in Blood
65
242
2.72
12.52
2.5
3.1
%
55.8
57.3
0.18
42
166
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
105
489
2.18
12.43
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
72
284
2.57
12.38
1.7
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
36
94
3.86
12.34
1.1
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
105
491
2.17
12.31
1.2
1.3
—
20.0
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
32
77
4.19
12.23
1.2
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
81
340
2.42
12.22
1.0
1.1
g/l
1.5
1.5
0.25
72
301
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
25
49
5.13
12.20
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3149
30123
1.63
12.14
19.6
12.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
465
3327
1.46
12.02
2.6
2.6
umol/l
5.8
7.5
1.72
398
2859
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
95
432
2.23
11.94
1.2
1.3
u/ml
112.8
114.4
0.05
18
93
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
33
83
4.01
11.91
1.0
1.1
%
93.2
88.6
0.46
20
40
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
90
401
2.28
11.87
1.3
1.3
nmol/l
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
96
440
2.22
11.84
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
143
762
1.92
11.75
2.7
2.3
%
181.7
188.6
0.39
130
722
(3000093) Morphology [Interpretation] in Blood Narrative
58
212
2.77
11.60
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
180
1036
1.78
11.57
2.2
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
67
264
2.57
11.57
1.8
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
136
718
1.93
11.49
2.7
2.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
64
254
2.55
10.91
13.6
5.7
mmol/l
6.8
7.3
0.80
54
206
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
33
89
3.73
10.84
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
31
80
3.90
10.83
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
189
1128
1.72
10.72
2.5
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1570
13687
1.27
10.64
4.4
3.9
—
—
—
0
0
(4010399)
310
2097
1.53
10.53
1.6
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
51
184
2.80
10.48
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
31
82
3.81
10.47
1.0
1.3
%
97.3
91.4
0.42
20
40
(3028433) Virus identified in Specimen by Culture
32
87
3.70
10.40
1.1
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
371
2613
1.47
10.35
7.9
7.4
%
96.0
95.9
0.12
355
2517
(3024263) Appearance of Synovial fluid
42
137
3.09
10.31
2.2
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
262
1715
1.57
10.31
4.7
5.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
58
226
2.59
10.28
1.2
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2989
28425
1.43
10.24
5.0
4.6
mmol/l
5.6
5.9
30.99
2744
25855
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
88
414
2.16
10.22
1.1
1.1
u/ml
4.0
3.4
0.13
17
191
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
250
1623
1.58
10.19
1.8
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
35
103
3.42
10.13
4.1
5.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
81
371
2.21
10.06
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
92
444
2.10
10.02
1.1
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
327
2262
1.49
9.98
8.3
6.2
mmol/l
1.3
1.3
0.03
317
2186
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
42
140
3.03
9.95
1.8
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
54
207
2.63
9.90
1.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
42
141
3.00
9.83
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
373
2657
1.45
9.80
1.7
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
685
5404
1.34
9.76
4.1
3.5
ng/l
208.5
289.3
0.57
512
4057
(3012501) Base excess in Blood by calculation
112
587
1.94
9.72
3.8
3.8
mmol/l
2.6
2.8
0.28
79
408
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
51
192
2.68
9.70
1.1
1.1
u/ml
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
52
198
2.65
9.67
1.4
1.1
mg/l
32.7
36.2
0.42
44
168
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
53
205
2.61
9.56
1.0
1.0
mg/l
304.0
296.7
0.32
48
176
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
50
188
2.68
9.53
1.2
1.1
mg/l
205.0
241.8
1.43
44
166
(3014576) Chloride [Moles/volume] in Serum or Plasma
441
3257
1.41
9.49
7.8
6.2
mmol/l
104.0
104.4
0.96
425
3197
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
161
2.82
9.42
1.8
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
410
2993
1.42
9.42
7.6
6.9
mmol/l
1.1
1.2
0.29
329
2336
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
92
455
2.05
9.41
1.3
1.2
nmol/l
0.2
0.4
—
5
21
(44790049)
68
298
2.31
9.40
1.3
1.3
—
—
—
0
0
(44806118)
68
298
2.31
9.40
1.3
1.3
—
—
—
0
0
(44790048)
68
298
2.31
9.40
1.3
1.3
—
—
—
0
0
(44790047)
68
298
2.31
9.40
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
301
2074
1.50
9.36
9.8
7.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
118
641
1.87
9.21
2.7
2.9
mg/l
1.6
1.5
0.12
109
591
(3021447) Carbon dioxide [Partial pressure] in Venous blood
330
2327
1.46
9.13
4.9
3.4
kpa
5.9
5.8
0.36
322
2267
(3010421) pH of Blood
126
705
1.82
8.96
3.7
3.7
ph
7.4
7.4
0.07
111
577
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
319
2247
1.46
8.88
2.1
2.3
ug/l
5.5
6.2
0.27
261
1937
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
85
421
2.05
8.69
1.4
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
407
3011
1.40
8.65
7.7
6.9
kpa
5.0
5.1
0.81
386
2871
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
38
130
2.94
8.65
1.6
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
38
130
2.94
8.65
1.6
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
55
229
2.42
8.55
1.3
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
27
75
3.62
8.55
1.3
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
27
75
3.62
8.55
1.1
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
406
3009
1.40
8.53
7.7
6.9
kpa
12.3
12.7
0.68
386
2866
(3036670) Protein [Mass/volume] in Synovial fluid
29
85
3.43
8.49
1.3
1.2
g/l
38.9
39.0
0.01
17
41
(3003181) Sodium [Moles/volume] in Urine
101
537
1.91
8.45
1.5
1.3
mmol/l
60.5
59.9
0.05
85
439
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
38
132
2.90
8.43
2.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
38
132
2.90
8.43
2.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
38
132
2.90
8.43
2.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
38
132
2.90
8.43
2.0
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
123
697
1.79
8.41
1.4
1.2
mg/l
407.3
505.1
3.60
118
658
(40761539) Cells [Type] in Urine sediment by Light microscopy
24
62
3.89
8.41
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
180
1132
1.62
8.41
4.8
3.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
50
201
2.51
8.38
1.5
1.5
u/l
7.8
6.5
0.16
29
96
(3002032) Base excess in Venous blood by calculation
323
2317
1.44
8.16
5.0
3.4
mmol/l
1.8
2.0
0.36
269
1915
(3017704) Immunofixation for Urine
37
130
2.87
8.05
1.9
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
11
14
7.88
7.99
1.1
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
121
695
1.77
7.93
1.3
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
18
39
4.63
7.87
1.2
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
51
215
2.39
7.75
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
69
332
2.10
7.66
1.7
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
241
1655
1.49
7.64
6.9
7.0
mmol/l
24.7
24.7
0.06
228
1531
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
40
151
2.67
7.63
1.1
1.1
u/l
30.3
23.5
0.40
29
108
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
40
151
2.67
7.63
1.1
1.1
u/l
96.2
78.6
0.88
32
113
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
238
1634
1.49
7.55
2.7
2.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
63
3.67
7.45
1.2
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
15
29
5.19
7.44
1.3
1.1
—
—
—
0
0
(44806071)
17
37
4.61
7.40
1.1
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
108
613
1.79
7.39
1.3
1.2
mmol/l
3.7
3.8
0.51
103
577
(3002173) Hemoglobin [Mass/volume] in Arterial blood
334
2456
1.40
7.34
8.4
7.7
g/l
117.3
119.2
1.12
323
2365
(42529406) Shigella sp [Presence] in Stool by Culture
146
905
1.64
7.27
1.3
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
135
821
1.67
7.23
2.5
2.0
%
93.5
92.7
0.14
124
758
(3042111) Morphology [Interpretation] in Bone marrow Narrative
85
451
1.91
7.21
1.2
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
15
30
5.02
7.18
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
144
897
1.63
7.04
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
94
520
1.83
7.02
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
142
888
1.63
6.84
1.3
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
17
40
4.27
6.74
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
48
211
2.29
6.69
1.3
1.6
u/ml
22.8
21.1
—
8
41
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
38
151
2.53
6.59
1.4
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
128
788
1.65
6.58
3.7
3.6
mmol/l
3.8
3.8
0.11
117
746
(3052851) Hemolysis interference index of Serum or Plasma
138
867
1.62
6.54
2.9
3.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
266
1919
1.42
6.53
4.8
2.8
kpa
4.2
4.6
3.05
260
1863
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
64
320
2.02
6.47
3.6
4.7
u/ml
154.8
77.6
0.49
21
94
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
78
420
1.88
6.37
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
464
3668
1.31
6.34
7.6
6.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
41
173
2.39
6.28
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
52
243
2.16
6.28
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
42
180
2.35
6.22
1.1
1.1
nmol/l
5.1
14.3
0.39
14
34
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
41
174
2.37
6.21
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
132
833
1.61
6.17
2.1
2.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
214
1500
1.46
6.16
4.4
3.5
—
—
—
0
0
(4027681)
37
151
2.47
6.10
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
48
221
2.19
6.03
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
293
2181
1.38
6.00
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
216
1525
1.44
5.99
1.7
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
42
184
2.30
5.94
1.0
1.1
iu/ml
13.4
10.3
0.21
11
47
(3007461) Platelets [#/volume] in Blood
3267
31987
1.58
5.93
33.4
20.2
e9/l
256.4
259.3
1.84
3230
31174
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
362
2790
1.33
5.92
2.2
2.3
u/l
43.2
38.9
0.33
298
2376
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
23
74
3.12
5.88
1.3
1.4
nmol/l
216.7
100.9
1.39
14
52
(3045142) Bone marrow Pathology biopsy report
61
311
1.98
5.88
1.2
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
34
136
2.52
5.85
1.6
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
99
589
1.70
5.83
2.6
2.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
27
96
2.83
5.83
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
31
119
2.62
5.80
2.4
3.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
3267
31997
1.57
5.79
33.2
20.1
fl
91.4
91.1
3.13
3242
31536
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
103
621
1.68
5.78
1.5
1.4
e6/l
35.7
1587.7
2.67
87
496
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
49
232
2.13
5.76
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
157
1049
1.52
5.74
4.6
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
42
187
2.26
5.73
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3267
32002
1.57
5.73
33.4
20.2
e12/l
4.4
4.4
15.71
3222
31095
(3010813) Leukocytes [#/volume] in Blood
3267
32005
1.56
5.69
33.4
20.2
e9/l
6.3
6.6
7.94
3222
31091
(3000963) Hemoglobin [Mass/volume] in Blood
3267
32010
1.56
5.62
33.6
20.3
g/l
130.6
132.9
20.73
3243
31549
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
37
4.07
5.62
1.1
2.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
3266
32000
1.56
5.60
33.2
20.1
pg
30.2
30.2
0.10
3241
31537
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
102
619
1.67
5.59
1.4
1.3
e6/l
3.8
28.2
1.98
80
465
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
66
3.20
5.59
1.1
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
24
82
2.94
5.56
2.0
2.4
%
140.1
168.0
0.72
24
74
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
51
249
2.06
5.55
1.3
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
32
128
2.51
5.53
1.5
1.5
—
—
—
0
0
(4035726)
360
2800
1.32
5.52
1.4
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
21
5.25
5.52
2.4
5.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
41
184
2.24
5.51
1.1
1.4
—
511.1
—
0
18
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
29
4.50
5.51
1.5
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
73
406
1.82
5.44
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
150
1005
1.52
5.43
2.4
1.9
s
20.9
21.2
0.35
123
866
(3023183) Ammonium ion [Moles/volume] in Plasma
87
510
1.72
5.43
2.3
2.9
umol/l
29.3
33.6
1.18
74
437
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
171
1180
1.47
5.37
5.5
2.5
%
0.7
0.6
0.74
162
1130
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
28
107
2.63
5.31
2.2
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
67
366
1.85
5.30
2.4
2.1
mg/l
23.4
25.5
0.12
18
98
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
828
1.55
5.22
1.3
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
40
182
2.21
5.22
1.1
1.4
—
64.1
—
0
17
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
147
992
1.50
5.16
5.1
3.6
mmol/l
24.9
25.1
0.40
130
909
(40768795) Lymph node Pathology biopsy report
61
328
1.88
5.08
1.4
1.2
—
—
—
0
0
(44813793)
45
218
2.08
5.03
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1056
9344
1.19
5.01
2.5
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
165
1153
1.45
4.88
1.6
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
359
2841
1.29
4.86
1.6
1.7
%
1.4
1.4
0.24
306
2492
(4015189)
20
67
3.00
4.82
1.8
2.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
12
28
4.30
4.82
1.3
1.3
mmol/l
5.3
5.9
—
7
16
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
107
2.54
4.79
2.3
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
107
2.54
4.79
2.3
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2968
28746
1.26
4.68
4.7
4.4
mmol/l
4.7
4.8
13.53
2752
26515
(3016038) Potassium [Moles/volume] in Urine
40
191
2.11
4.66
1.2
1.1
mmol/l
30.0
33.9
0.66
34
163
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
86
2.69
4.58
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
43
213
2.03
4.56
1.4
1.2
u/ml
0.3
1.1
0.77
18
92
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
75
2.81
4.54
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
274
2110
1.32
4.54
2.0
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
38
180
2.12
4.53
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
172
2368
0.71
4.53
1.4
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
32
143
2.25
4.40
1.4
1.9
u/field
2.3
2.0
0.10
25
94
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
73
434
1.70
4.40
1.5
1.4
u/l
27.9
31.3
0.39
61
359
(3013005) Retinol [Moles/volume] in Serum or Plasma
28
118
2.38
4.39
1.2
1.6
umol/l
1.8
2.1
1.36
20
109
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
137
2.27
4.38
1.1
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
13
35
3.72
4.36
1.0
1.2
u/ml
0.0
0.9
—
8
19
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
138
2.26
4.31
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
18
61
2.96
4.28
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3016
29315
1.26
4.27
5.2
4.9
mmol/l
2.7
2.8
9.45
2794
26884
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
164
1177
1.41
4.24
6.1
3.7
mmol/l
24.1
24.2
0.26
146
1064
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
807
7063
1.19
4.23
2.4
2.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
25
102
2.46
4.21
1.1
1.1
ng/l
29.7
700.1
—
6
22
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
103
2.44
4.13
1.8
2.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
24
97
2.48
4.12
1.2
1.3
%
118.3
111.3
0.77
24
86
(3051387) C reactive protein [Mass/volume] in Capillary blood
93
599
1.57
4.11
6.3
3.6
mg/l
22.3
24.8
0.33
60
361
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
42
215
1.97
4.11
4.7
6.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
211
1589
1.35
4.09
1.1
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
35
168
2.09
4.07
1.2
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
37
3.52
4.05
1.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2845
27517
1.21
4.02
4.2
3.9
mmol/l
1.2
1.3
2.42
2602
25010
(3016018) Differential panel - Cerebral spinal fluid
53
296
1.80
3.99
1.3
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
20
75
2.68
3.98
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
89
573
1.57
3.95
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
89
573
1.57
3.95
1.3
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
48
261
1.85
3.94
1.8
1.8
ug/l
18.0
19.9
0.23
48
256
(3009214) Lutropin [Units/volume] in Serum or Plasma
81
511
1.60
3.92
1.2
1.3
u/l
13.9
14.9
0.24
63
415
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
67
404
1.67
3.87
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
89
577
1.56
3.84
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
65
391
1.68
3.80
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
65
391
1.68
3.80
1.3
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
29
3.80
3.80
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
24
102
2.36
3.73
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
65
394
1.66
3.70
1.3
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
12
6.68
3.67
1.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
65
395
1.66
3.67
1.3
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
9
16
5.64
3.65
1.1
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
18
67
2.70
3.65
1.4
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
121
848
1.44
3.61
1.9
1.8
iu/l
4.2
4.6
0.17
39
310
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
9
7.79
3.56
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
69
430
1.62
3.54
1.1
1.1
u/ml
4.6
4.1
0.12
36
198
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
20
80
2.51
3.54
1.1
1.2
—
—
—
0
0
(4306422)
67
415
1.63
3.53
1.3
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
16
57
2.82
3.52
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
164
1218
1.36
3.51
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
116
814
1.44
3.46
1.4
1.7
mu/l
274.6
315.6
1.59
101
732
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
35
180
1.95
3.43
1.4
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
35
180
1.95
3.43
1.6
1.8
mmol/24h
4.9
8.1
—
5
9
(3024522) Salmonella sp identified in Specimen by Organism specific culture
64
398
1.62
3.33
1.3
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
71
2.54
3.29
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
71
2.54
3.29
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
64
400
1.61
3.27
1.1
1.1
%
123.3
120.4
0.21
55
348
(3009508) Creatinine [Moles/volume] in Urine
954
8616
1.15
3.24
3.2
3.0
mmol/l
6.5
6.8
0.86
795
7194
(3004716) Salmonella sp identified in Stool by Organism specific culture
196
1515
1.31
3.23
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
179
2318
0.76
3.21
1.7
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
66
2.58
3.21
1.6
1.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
29
144
2.02
3.15
1.3
1.3
nmol/l
129.1
132.7
0.16
29
144
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2931
28554
1.19
3.15
4.7
4.4
mmol/l
1.5
1.6
1.43
2704
26183
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
85
2.36
3.15
1.5
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
34
179
1.91
3.14
1.4
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
34
3.24
3.05
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
30
153
1.97
3.04
1.1
1.1
u/l
1.1
1.1
0.01
11
81
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
23
106
2.18
3.02
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
316
1.66
3.00
1.2
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
21
4.29
2.99
1.9
2.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
11
35
3.15
2.93
1.3
2.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
114
825
1.40
2.91
2.3
1.9
u/l
4397.3
4310.3
0.01
45
328
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
10
30
3.34
2.90
1.1
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
52
2.70
2.88
1.1
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
13
5.39
2.87
1.3
1.5
umol/24h
215.9
335.0
—
7
13
(3004119) Hemoglobin [Mass/volume] in Venous blood
199
1569
1.29
2.86
5.6
3.0
g/l
125.4
127.6
0.80
192
1531
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
244
1.73
2.86
1.1
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
50
305
1.65
2.86
1.2
1.4
mosm/kgh2o
278.5
275.9
0.44
41
235
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
31
164
1.90
2.85
1.1
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
47
2.77
2.81
2.5
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
36
3.06
2.80
1.0
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
453
3909
1.18
2.77
1.3
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
48
294
1.64
2.71
1.1
1.1
%
93.6
97.2
0.49
41
271
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
73
493
1.49
2.71
1.2
1.1
u/ml
1.5
1.4
0.03
34
177
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
66
2.43
2.70
1.1
1.1
umol/24h
0.5
0.7
—
8
36
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
54
2.60
2.70
1.3
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
63
413
1.54
2.69
1.1
1.1
u/ml
0.6
1.1
0.50
29
168
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
44
264
1.68
2.69
1.4
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
37
2.98
2.69
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
23
112
2.06
2.67
1.2
1.1
miu/ml
1546.0
1604.3
0.08
23
112
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
32
3.13
2.64
1.2
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
84
588
1.44
2.62
2.3
3.3
u/ml
135.0
977.1
1.15
75
536
(3017446) Testosterone [Moles/volume] in Serum or Plasma
101
731
1.39
2.62
2.2
2.0
nmol/l
11.5
11.1
0.21
83
643
(3023323) Follitropin [Units/volume] in Serum or Plasma
189
1501
1.27
2.60
1.4
1.3
iu/l
35.8
32.9
0.48
167
1304
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
38
2.90
2.58
1.5
2.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
286
2382
1.22
2.57
2.1
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
43
260
1.66
2.57
2.2
2.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
56
2.51
2.53
6.1
4.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
32
179
1.80
2.51
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
882
8048
1.13
2.49
1.6
1.6
mmol/l
1.3
1.4
0.27
713
6800
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
34
2.95
2.41
1.2
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
12
5.01
2.40
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
702
6330
1.14
2.38
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
30
169
1.78
2.32
1.6
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
20
98
2.05
2.31
1.3
1.6
ug/l
0.4
0.4
0.20
14
61
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
35
2.86
2.30
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
62
421
1.48
2.29
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
85
2.12
2.28
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
134
1.87
2.26
1.1
1.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
7
18
3.89
2.25
1.0
1.1
—
—
—
0
0
(4034850)
124
953
1.31
2.23
12.8
8.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
93
2.05
2.21
4.1
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
890
8178
1.12
2.20
3.3
3.1
mg/l
811.1
378.7
1.01
513
4752
(3022493) Free Hemoglobin [Mass/volume] in Plasma
20
100
2.01
2.20
1.1
6.0
mg/l
50.8
65.6
0.75
15
69
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
168
1349
1.26
2.16
11.0
8.5
mmol/l
24.2
24.4
0.31
158
1258
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
452
1.45
2.15
1.5
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
19
3.69
2.15
2.0
2.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
30
3.00
2.14
1.9
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
18
88
2.05
2.11
1.6
1.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
11
43
2.56
2.09
1.5
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
356
0.53
2.07
1.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
7
20
3.50
2.05
5.1
4.8
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
25
139
1.80
2.04
1.6
1.7
nmol/l
2.4
6.5
1.27
17
110
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
15
4.00
2.04
1.2
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
56
384
1.47
2.01
1.0
1.1
u/ml
0.2
2.4
2.48
11
94
(3047352) Trisomy 18 risk [Likelihood] in Fetus
24
416
0.57
2.01
1.6
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
26
3.08
2.01
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
26
3.08
2.01
1.3
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
145
0.34
2.01
37.8
15.1
nmol/l
1234.4
1563.7
—
5
140
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
255
1.58
2.00
1.4
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
45
296
1.53
1.97
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
24
413
0.58
1.97
1.5
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
41
265
1.55
1.95
1.1
1.1
nmol/l
350.3
385.3
0.44
34
232
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
264
2247
1.19
1.95
2.5
3.7
u/ml
27.8
59.6
5.37
253
2164
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
125
1578
0.78
1.94
1.5
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
28
164
1.71
1.94
1.6
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
27
2.97
1.93
1.1
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
16
3.75
1.93
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
39
2.57
1.92
1.7
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
24
135
1.78
1.91
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
43
283
1.53
1.89
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
141
0.35
1.87
21.2
11.3
nmol/l
811.2
871.2
—
5
135
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
34
2.65
1.86
2.7
2.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
19
100
1.91
1.85
16.0
26.3
ug/l
103.8
108.6
0.16
12
86
(3020682) Albumin/Creatinine [Ratio] in Urine
926
8602
1.11
1.84
4.0
3.8
mg/mmol
7.6
8.0
0.11
530
5033
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
59
417
1.42
1.84
1.2
1.2
u/l
23.2
30.1
0.59
52
361
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
17
3.53
1.83
1.2
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.17
1.82
1.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
26
427
0.61
1.80
1.7
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
32
199
1.61
1.80
1.1
1.3
mmol/l
14.6
11.7
—
6
49
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
60
2.17
1.77
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
23
131
1.76
1.77
2.0
3.8
ph
7.4
7.4
0.12
11
42
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
146
1.72
1.77
1.2
1.1
—
—
—
0
0
(3036603) Volume of Urine
32
201
1.60
1.74
1.6
1.4
ml
1939.8
1920.6
—
5
37
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
22
125
1.76
1.71
2.1
2.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
24
140
1.72
1.71
1.1
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
17
89
1.91
1.69
31.2
30.1
ug/l
6.7
7.2
0.47
17
80
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
104
816
1.28
1.68
1.5
1.3
miu/ml
193.3
225.7
0.44
42
399
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
10
42
2.39
1.67
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
31
2.58
1.66
3.9
5.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
536
0.67
1.64
1.7
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
69
916
0.75
1.61
1.8
1.5
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.58
1.61
1.2
1.0
%
20.0
21.7
—
5
14
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.58
1.61
1.2
1.0
%
7.4
8.2
—
5
14
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.58
1.61
1.2
1.0
%
36.7
37.5
—
5
14
(3050129) First trimester maternal screen panel - Serum or Plasma
41
593
0.69
1.61
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
23
136
1.70
1.58
1.5
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
135
1102
1.23
1.58
5.5
5.8
%
1.7
1.6
0.50
125
1032
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
1377
1.21
1.56
11.0
9.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
12
57
2.11
1.55
1.7
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
24
145
1.66
1.54
5.4
3.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
58
424
1.37
1.54
1.2
1.4
nmol/l
0.4
0.3
0.03
41
318
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
33
2.43
1.53
1.0
1.2
—
—
—
0
0
(4094501)
98
775
1.27
1.51
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
40
274
1.47
1.51
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
812
1.26
1.50
2.9
3.2
u/ml
0.4
0.4
0.25
58
468
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
45
2.23
1.46
1.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
18
102
1.77
1.44
3.4
2.1
umol/l
63.0
54.5
0.35
11
81
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
16
3.13
1.44
1.2
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
81
1.86
1.40
1.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
501
0.70
1.34
1.4
1.4
—
—
—
0
0
(4211845)
25
159
1.58
1.34
5.2
3.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
500
0.70
1.33
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
499
0.70
1.32
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
222
1934
1.16
1.31
1.7
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
498
0.70
1.31
1.4
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
24
2.50
1.30
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
44
318
1.39
1.29
1.5
1.7
—
3.2
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
48
2.09
1.27
2.4
2.4
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
12
62
1.94
1.27
1.3
1.3
mg/l
0.6
72.3
—
7
49
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
20
122
1.64
1.27
1.8
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
20
122
1.64
1.27
1.8
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
39
277
1.41
1.26
1.3
1.5
—
1680.0
—
0
5
(3034274) Bile acid [Moles/volume] in Serum --fasting
41
294
1.40
1.26
1.9
2.0
umol/l
10.1
6.1
0.99
25
209
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
19
115
1.66
1.24
1.7
2.4
umol/l
88.6
179.7
—
10
58
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
422
0.68
1.24
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
57
433
1.32
1.23
1.3
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
8
37
2.16
1.21
1.1
1.9
mmol/l
1.4
3.4
—
8
32
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
37
2.16
1.21
1.0
1.1
umol/24h
1.7
1.6
—
8
37
(3007930) Methemoglobin/Hemoglobin.total in Blood
131
1101
1.20
1.21
5.6
5.8
%
0.9
0.9
0.17
121
1031
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
33
230
1.44
1.19
2.2
2.1
u/field
2.3
2.5
0.06
16
86
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
71
1.83
1.19
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
26
2.31
1.18
2.0
2.7
u/field
0.7
0.8
—
6
26
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
26
2.31
1.18
1.0
2.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
44
324
1.36
1.17
2.9
3.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
153
1311
1.17
1.14
1.6
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
167
1444
1.16
1.12
1.9
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
32
2.19
1.08
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
706
1.22
1.04
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
75
1.74
1.02
1.4
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
13
75
1.74
1.02
1.2
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
101
849
1.20
0.97
6.7
7.1
mmol/l
1.2
1.2
0.09
89
749
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
84
1.67
0.97
1.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
307
0.68
0.96
1.6
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
19
124
1.54
0.96
1.2
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
77
1.69
0.95
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
51
1.77
0.94
1.0
1.3
ng/l
49.8
86.3
—
9
51
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
266
2406
1.11
0.94
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
133
1.51
0.94
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
66
534
1.24
0.93
8.8
2.8
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
27
2.22
0.93
1.3
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
27
2.22
0.93
1.2
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
41
312
1.32
0.93
1.0
1.1
u/ml
1.7
4.2
1.36
14
116
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
21
142
1.48
0.92
1.0
1.1
u/ml
9.3
7.0
—
6
16
(3039000) Anion gap in Blood
74
609
1.22
0.90
7.6
8.3
mmol/l
10.8
11.0
0.33
65
548
(3014271) Vancomycin [Susceptibility]
21
143
1.47
0.89
3.0
2.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
74
610
1.22
0.89
7.6
8.3
mmol/l
104.3
104.9
0.65
65
549
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.07
0.89
1.2
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
32
237
1.35
0.87
1.5
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
64
1.72
0.86
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
60
486
1.24
0.86
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
204
0.64
0.85
1.6
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
39
301
1.30
0.82
1.5
1.9
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
32
1.88
0.81
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
400
3723
1.08
0.81
4.4
4.6
%
33.4
33.2
0.18
278
2444
(3017569) Oxygen content in Arterial blood
18
122
1.48
0.80
1.9
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
98
1.53
0.78
1.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
199
0.65
0.78
1.3
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
74
1.62
0.78
1.7
3.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
74
1.62
0.78
1.7
3.7
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.9
—
1.3
—
0
17
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
33
252
1.31
0.76
1.5
1.5
e6/l
115393.1
80393.6
0.17
13
135
(3033705) Calcium.ionized [Moles/volume] in Venous blood
41
324
1.27
0.74
3.3
2.2
—
—
—
0
0
(4024509)
43
342
1.26
0.74
2.4
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
54
1.67
0.74
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
25
2.00
0.72
1.2
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
146
1632
0.89
0.70
1.7
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
9
58
1.55
0.69
1.9
1.9
mmol/l
3.6
1.7
—
9
52
(3020874) Milk IgE Ab [Units/volume] in Serum
21
152
1.38
0.69
1.1
1.0
u/ml
0.2
1.9
—
8
48
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
27
1.85
0.68
2.0
1.8
umol/l
45.4
41.6
—
5
27
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
61
1.64
0.68
1.1
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
61
1.64
0.68
2.7
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
963
9984
0.95
0.68
3.0
2.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
29
374
0.77
0.67
2.3
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
205
1.32
0.67
1.3
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(4281824)
36
451
0.80
0.66
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
46
375
1.23
0.66
1.6
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
95
0.53
0.66
1.0
2.4
nmol/l
145.8
150.6
—
5
82
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
345
3224
1.08
0.66
2.8
4.0
ug/l
11.4
23.3
0.80
273
2562
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
17
236
0.72
0.64
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
308
2871
1.08
0.63
4.7
4.9
ug/l
1.9
2.5
1.92
270
2517
(3011648) Oxygen content in Venous blood
15
211
0.71
0.62
2.9
2.0
%
10.2
10.7
0.26
15
211
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
49
1.63
0.62
1.1
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
42
343
1.23
0.61
1.0
1.0
u/ml
5.2
3.0
0.20
16
120
(3003434) Protein [Mass/volume] in Pleural fluid
39
316
1.24
0.61
1.4
1.5
g/l
28.1
32.8
1.07
33
286
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
123
1100
1.12
0.60
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
66
565
1.17
0.59
2.7
3.2
nmol/l
0.8
0.8
0.08
51
439
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
343
3223
1.07
0.58
1.7
1.7
—
—
—
0
0
(4146454)
24
310
0.77
0.58
2.2
2.8
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
23
0.00
0.58
0.0
1.5
—
7.4
—
0
14
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
39
318
1.23
0.58
1.0
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
35
282
1.24
0.58
1.6
1.5
e6/l
2780.7
2395.0
0.07
21
198
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
257
1.25
0.55
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
124
1117
1.11
0.55
1.8
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
38
1.58
0.54
1.3
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
57
488
1.17
0.53
2.0
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
161
1.31
0.51
1.1
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
48
407
1.18
0.50
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
10
67
1.49
0.49
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
48
408
1.18
0.49
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
262
1.22
0.48
3.1
2.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
48
1.46
0.46
1.7
2.2
umol/l
18.1
17.4
—
7
48
(1001926) Buprenorphine [Presence] in Urine by Screen method
60
523
1.15
0.46
1.6
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
50
1.40
0.45
1.1
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
17
130
1.31
0.44
1.6
2.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
128
0.70
0.43
1.4
9.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
371
0.83
0.42
1.3
1.3
mmol/l
6.4
7.5
0.77
21
277
(3033799) Differential panel - Peritoneal fluid
6
94
0.64
0.42
2.8
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
94
0.64
0.42
1.7
2.0
—
—
—
0
0
(4133840)
8
57
1.40
0.42
1.1
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
139
0.72
0.42
11.7
11.9
mmol/l
0.8
0.6
—
10
126
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
243
2291
1.07
0.41
4.0
4.2
%
23.2
21.3
1.24
106
1079
(3016879) Cocaine [Presence] in Urine
69
614
1.13
0.41
1.5
1.6
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
0.9
—
0
10
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
6.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
51
446
1.15
0.39
1.6
2.2
—
—
—
0
0
(4198724)
10
71
1.41
0.39
1.1
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
731
7518
0.96
0.37
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
67
600
1.12
0.37
1.9
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
107
1.31
0.37
1.4
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
33
281
1.18
0.36
1.0
1.1
u/ml
0.1
0.3
—
7
69
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
108
1.30
0.35
1.1
1.4
iu/ml
—
119830.0
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
25
208
1.20
0.35
3.1
2.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
73
1.37
0.34
2.3
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2406
24271
0.97
0.34
28.4
17.7
g/l
330.3
331.0
3.70
2396
24101
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
20
163
1.23
0.34
1.5
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
45
1.33
0.33
2.8
3.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
191
1.21
0.33
2.5
3.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
74
673
1.10
0.33
1.5
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
73
667
1.10
0.30
1.5
1.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
15
120
1.25
0.30
2.7
2.0
mmol/l
7.0
9.4
—
10
97
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
176
1669
1.06
0.29
2.9
3.0
ug/l
0.7
0.8
0.62
116
1088
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
67
612
1.10
0.28
3.5
2.4
ug/min
92.1
86.5
0.05
40
364
(3027008) Opiates [Presence] in Urine
73
670
1.09
0.28
1.5
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
261
1.15
0.27
1.5
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
74
0.68
0.26
1.4
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
30
264
1.14
0.24
3.3
2.7
mg/l
21.1
22.6
0.05
23
186
(3027944) Amphetamines [Presence] in Urine
71
658
1.08
0.23
1.5
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
40
360
1.11
0.23
4.2
5.2
umol/l
340.0
367.8
0.58
34
317
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2624
26099
1.02
0.22
22.7
14.8
%
38.4
39.1
3.31
1762
18544
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
12.4
—
—
—
0
0
(3013862) HLA-DP [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
50
1.20
0.19
2.5
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
67
0.75
0.17
1.4
1.2
mmol/l
2.0
3.1
—
5
59
(3037556) Urate [Mass/volume] in Serum or Plasma
9
79
1.14
0.15
1.7
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
79
1.14
0.15
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
26
236
1.10
0.14
1.7
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
129
0.85
0.14
1.3
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
111
1068
1.04
0.14
2.2
3.3
u/ml
79.5
1626.7
0.98
97
902
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
98
0.82
0.13
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
77
735
1.05
0.13
6.4
4.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
85
1.18
0.12
1.2
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
15
133
1.13
0.12
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
38
405
0.94
0.11
1.4
1.1
iu/ml
68.5
1572.9
—
10
83
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
95
1.16
0.11
2.5
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
104
1073
0.97
0.10
1.9
1.7
mg/l
4.8
3.6
0.45
85
766
(3023511) Choriogonadotropin [Units/volume] in Urine
48
457
1.05
0.09
1.5
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
82
849
0.96
0.09
1.8
1.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
46
1.09
0.09
1.6
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
176
0.91
0.09
1.3
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
23
213
1.08
0.09
1.5
1.7
mmol/l
6.2
6.7
0.85
15
136
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
61
0.82
0.08
1.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
68
1.03
0.07
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
48
500
0.96
0.07
2.3
1.9
nmol/l
0.9
0.8
0.75
42
420
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
132
0.91
0.06
1.8
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
104
1023
1.02
0.04
1.4
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
16
168
0.95
0.02
1.3
1.4
—
1.6
—
0
13
(3026470) Cobalt [Mass/volume] in Blood
18
172
1.05
0.02
1.6
1.9
ug/l
3.8
3.1
0.21
13
152
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
20
193
1.04
0.01
1.0
1.0
ng/l
819.5
706.2
0.40
15
126
(3039443) Prostate specific Ag panel - Serum or Plasma
15
156
0.96
0.00
1.6
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
27
276
0.98
0.00
1.3
1.6
ug/l
2.5
4.4
0.94
22
226
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
142
0.99
0.00
1.2
1.6
mmol/l
8.1
8.1
—
8
87
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
214
0.98
0.00
1.5
1.5
g/l
0.9
1.0
0.70
21
214
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
20
196
1.02
0.00
1.0
1.0
ng/l
36.8
44.3
0.42
13
130
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
12
117
1.03
0.00
1.8
1.4
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
12.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
49
1.02
0.00
3.8
6.6
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
106.8
—
0
6
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(40757373) Influenza virus identified in Isolate
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
(44806420)
7
71
0.99
0.00
2.0
2.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
154.7
—
0
7
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
55
0.91
0.00
1.4
1.4
%
10.4
21.1
—
5
47
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.4
—
0
5
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
7.3
—
0
7
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
1.8
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint M13_SJOGREN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SJOGREN | 1.228 [1.13, 1.34] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.569 |
During the follow-up period (1.1.1998 — 31.12.2019), 2288 out of 13453 females with M13_SJOGREN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SJOGREN | 1.337 [1.17, 1.52] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 567 out of 2104 males with M13_SJOGREN died.
Mortality risk
Mortality risk for people of age
years, who have M13_SJOGREN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.136% | 0.263% |
| 5 | 0.727% | 1.381% |
| 10 | 1.872% | 3.951% |
| 15 | 3.798% | 7.568% |
| 20 | 6.677% | 12.721% |
Relationships between endpoints
↥Index endpoint: M13_SJOGREN – Sicca syndrome [Sjögren]
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data